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Dark chocolate (DC) is high in flavonoids, a bioactive micronutrient that increases the synthesis 
of nitric oxide (NO) and reduces the rate at which NO is removed from the blood. Nitric oxide is 
a potent vasodilator and its increase has potential to improve blood flow, delivery of oxygen to 
muscle, and endurance exercise performance, especially in conditions such as altitude, where 
hypoxia compromises delivery of oxygen to muscle. The purpose of this research was to 
investigate the effects of DC on cycling performance, metabolism, and blood oxygenation status 
in trained cyclists at altitude.  We hypothesized that DC would result in enhanced muscular 
oxygenation, more efficient exercise metabolism, and improved performance. Twelve trained 
cyclists (n=2 females, average VO2 peak=54.6±6.2 ml/kg/min) were randomized to supplement 
with 60g of DC or an isocaloric placebo twice per day for 14 days in a cross-over study. After 
the 2-weeks of supplementation, participants attended a lab session in which they cycled 90 
minutes at 60% VO2max followed immediately by a 10km time trial (TT) at a simulated altitude of 
2500m (15% O2).  Plasma levels of blood glucose and lactate were measured before, throughout, 
and after exercise while muscular and pre-frontal cortex oxygenation were measured 
continuously throughout exercise by near infrared spectroscopy. DC resulted in improved 
maintenance of blood glucose throughout the experimental trial (5.9±0.5 vs. 5.6±0.5 mmol/L; 
p=0.03) and decreased blood lactate following the time trial (7.7 mmol/L vs. 10.0 mmol/L, 
p=.027). DC had no effect on time trial performance (1142±129 vs. 1152±118 s for placebo) or 
oxygenation status in either the brain or muscle.  There was an increase in total hemoglobin and  
deoxygenated hemoglobin in the pre-frontal cortex, and an increase in total hemoglobin in the 
vastus lateralis over time.  Consumption of DC for two weeks prior to a bout of cycling at 
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simulated altitude allows for maintenance of blood glucose during exercise and decreased lactate 
production following intense and prolonged TT but does not improve TT performance.  Dark 
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Chapter 1: Introduction and Background 
1.1 Introduction 
     In elite sporting competitions, 0.5%-1.5% changes in performance are considered critical 
(Dominguez et al. 2017). Performance is especially challenging when athletes are competing at 
altitude (e.g. Tour de France mountain stages). Ascent to higher altitude leads to decreases in 
both maximal and submaximal exercise performance due to a decreased partial pressure of 
oxygen (PO2) (Beidleman et al., 2008). A drop in atmospheric PO2 leads to decreased arterial 
PO2 due to a decrease in pressure gradient, resulting in a proportional decrease in oxygen 
delivery to the muscle during exercise (Stenburg et al., 1966). 
     To maximize their potential, athletes often turn to nutritional supplementation as a way to 
further enhance their performance. Dietary supplementation with exogenous forms of nitrate (i.e. 
nitrate-rich beetroot juice or pure sodium nitrate) has become increasingly popular among 
endurance athletes due to its effects in reducing the oxygen cost of moderate-intensity exercise 
and improving performance (Cermak et al. 2012; Dominguez et al. 2017). When ingested, 
exogenous nitrate is converted to nitrite by facultative anaerobic bacteria in the oral cavity.  The 
nitrite is then acted upon by reducing compounds such as polyphenols, hemoglobin, myoglobin, 
and protons to produce nitric oxide (NO) (Lundberg et al. 2008) (see figure 1.1). NO can also be 
synthesized in the body through Nitric Oxide Synthase (NOS), an enzyme which catalyzes the 
production of NO from L-arginine (Delker et al. 2010). NO has various beneficial physiological 
effects such as improving oxygen uptake, increasing blood flow through vasodilation, improving 
muscle contractility, regulating myocyte differentiation, assisting in calcium and glucose 
homeostasis, and mitochondrial biogenesis (Cermak et al. 2012; Dominguez et al. 2017). 
     Nitrate supplementation may enhance performance through the actions of plasma NO.  
Dominguez et al. (2017) reviewed the effects of beetroot juice, the most popular form of nitrate 
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supplementation, on endurance exercise performance and concluded that acute supplementation 
with beetroot juice may lead to a decreased oxygen consumption (VO2) at intensities up to 
maximal oxygen consumption (VO2max) and may increase aerobic capacity while decreasing 
energy expenditure at the anaerobic threshold, suggesting an increase in metabolic efficiency.  
Supplementation with nitrate in the form of beetroot juice is effective in enhancing performance 
and mitigating some of the detrimental effects of altitude by decreasing oxygen consumption, 
improving time trial (TT) performance and increasing muscular oxygenation (Masschelein et al. 
2012; Muggeridge et al. 2014).  
     Evidence is emerging that suggests that dark chocolate (DC) may provide similar benefits. 
DC has been traditionally been seen as a food of high palatability and indulgence, which, when 
paired with potential performance-enhancing effects, makes it a food of great interest to 
endurance athletes. Various compounds making up DC increase the bioavailability of NO for the 
body and decrease the reuptake of NO while decreasing the amount of damage sustained by the 
muscle and increasing the rate at which a muscle recovers (Bayat et al. 2014; Faridi et al. 2008; 
Patel et al. 2015; Schewe et al. 2008; Sudarma et al. 2011). Thus, DC not only increases the 
amount of NO available for use by tissues but also decreases the rate at which NO is removed 
from the bloodstream.  An increase in serum NO may increase blood flow, helping to partially 
offset the detrimental effects of altitude. 
     With these prospective benefits to endurance performance, DC has the potential to become a 
very useful and enjoyable sport supplement for endurance athletes. With 85% of athletes 
reporting the use of supplements (Maughan et al., 2007), DC has the potential to aid thousands of 
elite and amateur athletes alike. Elite cycling races such as the Tour de France and the Giro 
d'Italia take athletes through various altitudes, ranging from nearly sea level to 4800 m, an 
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attitude corresponding to ~11.5% O2, almost half the amount of O2 found at sea level. The 
purpose of this study is to investigate the effects of 2 weeks of dark chocolate supplementation 
on performance and metabolic parameters of exercise at simulated altitude as well as oxygen 

















Figure 1.1. The pathway of nitric oxide (NO) production from the ingestion of exogenous 
nitrate.  Nitrate is reduced to nitrite in the oral cavity by anaerobic bacteria and further reduced to 
NO in the stomach through various pathways including hemoglobin, myoglobin, polyphenols, 
and protons.  NO leads to various performance enhancing effects such as improving glucose 
uptake, myocyte differentiation, mitochondrial biogenesis, muscle contractility, vasodilation, and 
oxygen uptake. 
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1.2 Review of the Literature 
      1.2.1 Role of Nitric Oxide During Exercise  
      Nitric Oxide is the by-product of the breakdown of other nitrogenous compounds, nitrate, 
and nitrite.  When exogenous nitrate (NO3-) is ingested, it is reduced to nitrite (NO2-) by 
facultative anaerobic bacteria in the oral cavity.  As the nitrite passes through the digestive 
system, it is further reduced to nitric oxide (NO) by reducing compounds such as polyphenols, 
hemoglobin, and myoglobin (Lundberg et al. 2008). NO is synthesized intracellularly through 
the action of a family of nitric oxide synthase (NOS) enzymes. These enzymes catalyze the 
NADPH and O2-dependent oxidation of L- arginine to L-citrulline and NO. NO is a signaling 
molecule for the cardiovascular system and is considered to be a critical modulator of cell and 
tissue function (Hill et al., 2010) and acts by activating guanylyl cyclase in vascular smooth 
muscle. This results in an increase in cyclic guanosine monophosphate which in turn activates 
myosin light-chain phosphatase, inducing relaxation (Pappano & Wier, 2012).  NO is crucial for 
its control of blood pressure, blood flow, and other vital bodily functions including regulation of 
intermediate metabolism and cellular energy production (Levett et al., 2011). It is classified as a 
free radical scavenger, combating the oxidative stress that the body undergoes due to oxidative 
metabolism.  
     Nitric oxide has various ergogenic effects on human performance.  One pertinent benefit is its 
role as a vasodilator.  When the endothelium undergoes shear stress due to increased blood flow 
caused by physical exertion, endothelial nitric oxide (eNO) is released from the vascular 
endothelium (Hill et al., 2010).  This nitric oxide acts on the smooth muscle of the local tissues 
to cause relaxation by hyperpolarizing the plasma membrane of the smooth muscle through 
activation of large-conductance KCa channels (Mughal et al., 2018). Other notable effects of NO 
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include improved muscle contractility, regulation of myocyte differentiation, assistance in 
calcium and glucose homeostasis, and enhancing mitochondrial biogenesis (Cermak et al. 2012; 
Dominguez et al. 2017). When taken before bouts of exercise, consumption of nitrate-rich 
beetroot juice decreases oxygen consumption (VO2) at intensities up to VO2max, which may 
increase aerobic capacity while decreasing energy expenditure at the anaerobic threshold 
(Dominguez et al. 2017).  This increase in efficiency increases time to exhaustion at submaximal 
intensities and may improve performance at the aerobic threshold (Dominguez et al. (2017) 
while directly improving time trial performance in cyclists (Lansley et al., 2011). 
     1.2.2 Effects of High Altitude on Human Performance 
     The effects of altitude on human performance are well documented (Beidleman et al., 2007; 
Drust & Waterhouse., 2010). As one reaches higher levels of altitude, barometric pressure 
decreases, decreasing the partial pressure of O2 (PO2) (McArdle et al., 2015). This decreased PO2 
leads to a decreased PO2 in the arteries (aPO2), bringing it down from 100 mmHg at sea level to 
~60 mmHg at 2400 m elevation.  The decreased aPO2 causes a decreased pressure gradient to 
occur between the arteries and skeletal muscle, decreasing the efficiency of oxygen diffusion to 
the muscles, decreasing the amount of O2 available for aerobic metabolism and forcing the body 
to undertake anaerobic metabolism, thus increasing the acidity in the blood, leading to increased 
measures of fatigue (Linnarsson et al., 1974).  The decreased PO2 gradient also leads to increases 
in minute ventilation, causing hyperventilation and hypocapnia, leading to a decrease in cerebral 
blood flow and increased central fatigue (Huang et al., 1984; Siebenmann et al., 2013). Even for 
those not attempting to pursue athletic endeavors, exposure to altitude can lead to various 
symptoms such as decreased motor skills, mood, and memory, a decrease in hearing and sight, 
lack of appetite, nausea, fatigue, headaches, insomnia, and, in extreme cases, high altitude 
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pulmonary or cerebral edema (McArdle et al., 2015).  The body's decreased ability to bring in 
and transport O2 also impacts the fuel of choice, both at rest and during exercise at any intensity. 
At altitude, carbohydrate metabolism has historically been seen as the metabolic pathway of 
choice due to its high level of ATP production per unit of O2 consumed (McClelland et al., 
1998). However, in endurance sporting events such as road cycling decreased levels of glycogen 
are known to cause fatigue and thus a decrease in performance (Snyder, 1998). Also, when 
metabolizing higher proportions of carbohydrates lactic acid is produced at a greater rate, which 
can be detrimental to performance (Cairns, 2006).  Thus, the ability to utilize fatty acids and 
spare muscle glycogen during exercise is seen as a preferential trait. O2 transport to bodily 
tissues is compromised during physical exertion involving large amounts of muscle mass (Billaut 
& Smith., 2010), potentially compromising cerebral oxygenation status, especially at the end of 
exhaustive exercise (Subudhi et al., 2007). This decrease in cerebral oxygenation status results in 
a decreased mitochondrial O2 to levels below what is needed to maintain motor function (Nybo 
et al., 2007). Exercise at altitude is also known to lower VO2max scores of athletes due to 
compromised transfer of O2 to the working muscles (Beidleman et al., 2008). The VO2 required 
for a given workload remains the same as at lower altitudes, but because the workload is now a 
greater percentage of maximal, it feels more difficult than if completed at lower altitudes. 
     It has been suggested that NO is an important signaling molecule for adaptation to 
altitude/hypoxia, as those who live in communities at altitude exhale higher concentrations of 
NO (Levett et al., 2011) and others have demonstrated that lower levels of expired NO coincide 
with increased incidence of altitude sickness (Duplain et al., 2000).  Dietary nitrate 
supplementation also reduces muscle metabolic perturbation during exercise in hypoxia 
(Masschelein et al., 2012) and improves the diffusion of O2 to tissues further away from 
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capillaries, creating a more precise matching of O2 delivery to metabolic demand (Vanhatalo et 
al., 2011). 
     Tissue oxygenation can be measured non-invasively using near-infrared spectroscopy (NIRS) 
(Artinis®, Einsteinweg, The Netherlands). The device uses 6 light-emitting diodes (3 pairs of 
LEDs) and one receiver.  External light must be blocked so as to not contaminate the reading 
with infrared light from external sources (Bishop et al., 2018). A quality control factor (QCF) is 
used to indirectly monitor external light to ensure a valid measurement. NIRS works on the 
principle that the absorbance of light by oxygenated and deoxygenated hemoglobin and 
myoglobin differs at different near-infrared lengths (MacDonald et al., 1999). This method of 
measuring oxygenation status has been validated for use in humans by Mancini and colleagues 
(1994), who also demonstrated that the NIRS signal was not influenced by skin blood flow or by 
the change in body and skin temperature with exercise  
1.2.3 Energy Metabolism During Exercise 
     To create useable energy from the food we ingest, the body must degrade macronutrients to 
the useable form of adenosine triphosphate (ATP).  During exercise, ATP is primarily created 
through glucose metabolism using glycolysis or in the electron transport chain after metabolism 
in the Krebs Cycle or through fatty acid metabolism using Beta-oxidation, the Krebs Cycle, and 
electron transport chain. Production of ATP from a glucose molecule through glycolysis results 
not only in ATP but also in pyruvate, which either is taken up by the mitochondria (where it 
enters the Krebs Cycle before the electron transport chain) to create more ATP or is converted to 
lactate.  Accumulation of lactate and its associated hydrogen ion leads to a decrease in pH, 
causing muscular pain and nausea as well as inhibition of muscular contraction, fatty acid 
oxidation, and the binding of O2 to hemoglobin, thus inhibiting the transfer of O2 to working 
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muscle (McKenna et al., 1997).  Thus, an accumulation of lactate is seen to be a contributor to 
fatigue of endurance performance.  Fatigue during endurance performance is also due to a 
decrease in stored glycogen and blood glucose.  During exercise, active muscle breaks down 
stored glycogen from within the muscle itself as well as draws glucose from the blood.  When 
blood glucose is diminished, stored glycogen in the liver is broken down to maintain stable blood 
glucose levels, ensuring the brain has a constant supply.  Thus, to spare glycogen stores and 
decrease the production of lactate, the ability to metabolize fatty acids at higher intensities of 
exercise is preferential.  
     Although a useful insight into bodily processes, measuring substrate usage during exercise 
has its complications. To estimate the percentage of carbohydrate and fatty acid usage, we use 
the O2 consumed and CO2 expired during exercise and apply them to equations (described by 
Jeukendrup and Wallis, 2005) to determine the primary macronutrient being metabolized. 
Carbohydrate and fat oxidation (in g/min) can be calculated using the following respective 
equations:  
𝐶𝐻𝑂𝑜𝑥 = 4.210 ∗ 𝑉𝐶𝑂2 − 2.962 ∗ 𝑉𝑂2 
𝐹𝐴𝑇𝑜𝑥 = 1.695 ∗ 𝑉𝑂2 − 1.701 ∗ 𝑉𝐶𝑂2 
Knowledge of the primary substrate being utilized lends itself to inferring metabolic efficiency, 
as a more efficient metabolic system will give preference to fatty acid metabolism.  By 
decreasing the body's reliance on carbohydrate, muscle glycogen will be spared, allowing more 
glycogen to be accessible when intensity increases, such as in a final sprint at the end of a race.  
1.2.4 Dark Chocolate on Human Physiology 
     Dark chocolate (DC) has been emerging as the subject of many endurance athletes' interest, as 
it has been suggested to increase endurance performance while providing a portion of the energy 
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endurance athletes need for optimal performance. DC is a food of plant origin (Theobroma 
cacao) and thus a rich source of flavonoids (Engler et al., 2004). Flavonoids have different 
subclasses, the most prominent being epicatechin (Nogueira et al., 2011). Epicatechin activates 
endothelial NOS and enhances endothelium-dependent relaxation (Karim et al., 2000) while 
diminishing the removal of NO in the bloodstream through the inhibition of NADPH Oxidase, 
which decreases the production of O2-, a known scavenger of NO (Schewe et al., 2008). DC is 
also a rich source of the flavonoid catechin, which increases the rate of lipolysis and has 
favorable effects on body composition (Maki et al., 2008), as well as procyanidins (polymers of 
catechins and epicatechins). Procyanidins modulate various cytokines in the body into reduce 
inflammatory effects (Ding et al., 2006). 
     In addition to increasing levels of serum NO in the body, DC is an energy-dense food and 
traditionally seen as being highly palatable, which could provide endurance athletes with a 
portion of the energy they require for performance. Road cycling is a highly aerobic sport with 
athletes traveling hundreds of kilometers at a time at high intensities. Tour de France riders have 
been found to expend a mean of 6,071 kcal per day (Saris et al. 1989), and their ability to 
properly fuel before, during, and after exercise is a large predictor of performance, as the ability 
of a muscle to produce ATP and complete long- term heavy exercise is dependent on muscle 
glycogen which is constantly being degraded during exercise (Bergström et al. 1967; Ørtenblad 
et al. 2013). DC contains approximately 560 kcal per 100 g of chocolate, lending it to be an easy 
method to maintain and restore glycogen levels during and after exercise. 
     DC is also a source of caffeine and theobromine, both of which have individual performance 
enhancing effects (Dodd et al., 1993). DC contains approximately 73 mg of caffeine and 883 mg 
of theobromine per 100g serving (Harland. 2000; Meng et al. 2009). Caffeine is one of the 
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world's most widely used drugs amongst athletes and non-athletes a like (Dodd et al., 1993). It 
has both physical and mental performance enhancing effects.  Caffeine acts at the cellular level 
by increasing the affinity of the myofilaments for calcium and increasing calcium release from 
the sarcoplasmic reticulum while inhibiting adenosine receptors (Graham, 2001), increasing 
lipolysis.  Caffeine acts on the adenosine receptors of the brain as well as peripheral receptors.  
By blocking adenosine receptors of the brain, caffeine inhibits the behavioral depression that 
activation of adenosine receptors cause, thus improving overall mood (Dodd et al., 1993).  
Theobromine, found primarily in chocolate (Mitchell et al., 2011), also blocks adenosine 
receptors, increasing muscular contractility and blocking adenosine receptors in both the brain 
and the periphery.  Unlike caffeine, theobromine also acts to lower blood pressure and acts as a 
smooth muscle relaxant, further increasing the vasodilatory effects of NO. 
1.2.5 Caffeine and Theobromine on Exercise Performance 
     Caffeine is well known for its many ergogenic effects on endurance exercise (Tarnopolsky, 
1994).  Some of these effects include, but are not limited to, increased time to fatigue in both 
running and cycling (Costill et al., 1978; Graham & Spriet, 1991), an increase in power output 
during 2-hour cycling (Costill et al., 1978), faster performance times in Nordic skiers at low and 
high altitudes(Berglund & Hemmingsson, 1982), increased force production (Westerblad & 
Allen, 1991), augmentation of plasma norepinephrine and plasma epinephrine to large-muscle, 
continuous exercise (Anderson & Hickey, 1994), and increased free fatty acid metabolism during 
exercise (Powers & Dodd, 1985). Caffeine has a half-life of 4-6 hours (Graham, (2001), and 
Quinlan et al. (1997) reported that peak plasma levels of caffeine are observed between 30-75 
minutes after ingestion when taken orally. However, it has been suspected that caffeine 
consumption 3 hours prior to long distance exercise is optimal, as this is when free fatty acid 
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levels are the highest due to the resultant lipolysis induced by caffeine ingestion (Nehlig & 
Debry, 1994). A review by Sökmen and colleagues (2008) suggests taking caffeine, at the latest, 
3 hours prior to power or short endurance events and 1 hour prior to longer endurance events.  
Graham (2001) has reported doses ranging from 3-9 mg/kg body weight to be effective for 
increasing endurance performance. Kovacs et al. (1998) have found that doses as low as 2.1 g/kg 
were effective, but doses ranging from 3.2-4.5 mg/kg had a greater effect.  Graham (2001) 
reports that doses of 3-6 mg/kg result in the greatest improvements in performance. Given that 
caffeine is both water and fat soluble, normalizing intake relative to fat-free mass is not 
necessary (McCall et al., 1982).  
     Theobromine is part of the drug class methylxanthines, along with caffeine.  Stellingwerff et 
al. (2013) observed an increase in plasma glucose levels during exercise that correlated with 
increased serum levels of theobromine, but not caffeine and theobromine is a phosphodiesterase 
inhibitor and adenosine receptor antagonist (Daly et al. 1987). Neufingerl and colleagues (2013) 
speculated that theobromine may be the component in DC that increases HDL cholesterol. 
Because theobromine is often found in conjunction with caffeine, timing and dosing 
recommendations have not been reported for theobromine independently.  
1.2.6 Effect of Dark Chocolate on Exercise Performance 
Dark chocolate as an ergogenic aid for athletic performance remains a relatively new area in the 
world of sport nutrition and exercise physiology. To date, there are a number of studies done on 
DC in a clinical population for improving clinical measures such as cardiovascular health, 
endothelial function, lipid profiles, among others (Araujo et al., 2016). However, the research in 
an athletic population remains scarce. There are conflicting views on the benefits of using DC to 
improve endurance performance.  
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     When looking at performance measures in endurance-based sport, time trials (TTs), time to 
exhaustion (TTE), and power output are often the outcome variables measured.  Patel and 
colleagues (2015) observed improvements in a 2-minute cycling TT performance, while 
Stellingwerff et al. (2013) and Peschek et al. (2014) found no change in cycling or running TTs, 
respectively.  This discrepancy could be due to the lengths of the TT the athletes underwent.  The 
Patel group had athletes complete a 2-minute time trial while the other studies mentioned 
assessed performance over a 5km running TT (lasting ~20 minutes) and a cycling TT lasting 
approximately 15 minutes.  The difference in the duration of the effort is likely a large 
contributor to the different findings of the studies. It has been demonstrated that an effort of ~2 
minutes is fueled by approximately equal parts anaerobic and aerobic energy systems (Astrand & 
Rodahl, 2003; Spencer & Gastin, 2001; Hill, 1999), while efforts of 15-20 minutes are fueled 
primarily by the aerobic system (Ward-Smith, 1985; Peronnet et al., 1989; Di Prampero et al., 
1993).  Thus, the differences in energy system contributions could be a large factor in the 
differences in finding between these studies.  
     Other measures of performance such as TTE, power output, and VO2max show similarly 
contradictory results. Sanguigni et al. (2017) assessed double product (a measure of myocardial 
oxygen uptake) and saw improvements in physical performance following ingestion of 100g of 
homemade cocoa antioxidant ice cream acutely, while Patel et al. (2015) and Fraga et al., (2005) 
saw no difference in VO2max scores following 2 week or acute ingestion of DC, respectively. 
However, Taub et al., (2016) observed an increase in VO2max scores following consumption of 
20g of DC daily for 3 months.  These results suggest that consumption for greater than 2 weeks 
is necessary to elicit an increase in VO2max. Taub et al. (2016) also found an increase in power 
output following chronic consumption, which agrees with a systematic review by Somerville et 
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al. (2017), who converted all measures to power output in order to make a direct comparison and 
found an increase in power output following chronic supplementation (for >7 days).  Patel et al. 
(2015) also analyzed gas exchange threshold (GET), an indicator of anaerobic threshold 
(Magalang & Grant, 1995), and found that acute consumption of DC led to an increased power 
output at the GET in moderately trained males (VO2max: 41.89 ± 5.4 ml/ kg/min). Due to the 
inconsistency in the literature regarding the effects of DC on exercise performance in endurance 
sports, it is clear that further research is needed to strengthen the evidence for or against DC as 
an ergogenic aid in endurance sport.  See table 1.1 below for a summary of the current literature 
on the topic.  
1.3 Conclusion 
 
Altitude can be detrimental to endurance exercise performance due to a decreased PO2 resulting 
in a decreased transfer of O2 to the brain and muscles, causing fatigue. Athletes often seek out 
nutritional supplementation to decrease detrimental effects and allow them to perform at their 
greatest potential while staying within anti-doping regulations.  Dark chocolate may be a 
beneficial supplement to assist exercise at altitude by increasing the bioavailability of NO, 
leading to increased vasodilation, decreased oxygen consumption at submaximal intensities, and 
increased metabolic efficiency.  Current research in the area remains scarce and inconsistent.   
Although some research has been done with chocolate at low altitudes, no research has been 
done at high altitudes to date and findings are conflicting, demonstrating the need for more 






































































































































































































































1.4 Purpose Statement and Hypothesis 
 
1.4.1 Purpose Statement 
Dark chocolate is rich in polyphenols and flavonoids which may increase the amount of nitrite 
that is converted to NO, enhancing vasodilation and exercise performance at altitude. Therefore, 
the primary purpose of this research was to determine the effects of 60g of dark chocolate twice 
daily for 14 days on time trial performance in trained cyclists at a simulated altitude of 2500 m 
(15% O2).  The secondary purpose was to investigate the effects of two weeks of dark chocolate 
supplementation on exercise metabolism, as assessed by measures of plasma glucose and lactate, 
oxygen consumption, and substrate (i.e. fat and carbohydrate) oxidation.  
1.4.2 Hypotheses 
The primary hypothesis was that supplementation with 60g of dark chocolate twice daily for two 
weeks prior to a 10 km time trial at a simulated altitude of 2500m would lead to improved 
cycling TT performance. 
The secondary hypotheses of this study are fourfold: 
Two weeks of dark chocolate supplementation before a bout of exercise at simulated altitude 
would: 
1) Enhance the metabolic efficiency of the body, as indicated by decreased plasma lactate 
concentrations and improved plasma glucose homeostasis, 
2) Decrease oxygen consumption, 
3) Increase reliance on fatty acids for ATP generation during constant-load, submaximal exercise 
performed at simulated altitude, and 




Chapter 2: Methods 
2.1 Study Design 
 
The study design was a double-blind counter-balanced cross-over study where dark chocolate 
was compared to a placebo condition. Twelve athletes were recruited and received both 
conditions. Participants and researchers involved in data collection and outcome assessment were 
blinded to whether dark chocolate or placebo were given and to the order in which participants 
received the conditions. This was accomplished by having separate researchers generate the 
randomization schedule (using a computerized random number generator) and prepare the dark 
chocolate or placebo. The allocation schedule was concealed from other researchers by the 
researcher who generated the randomized allocation schedule. When a participant entered the 
study, the condition assignment for that participant was revealed by the researcher who generated 
the allocation schedule to the researcher in charge of preparing the dark chocolate and placebo.  
The trial was registered at www.clinicaltrials.gov, NCT number NCT03945916. 
2.2 Participants 
Trained cyclists, triathletes, and duathletes were recruited to take part in this study.  The 
target sample size was 12 participants. 16 participants were recruited and provided consent, with 
4 participants failing to reach the required aerobic fitness scores in order to be classified as  
“trained” (see figure 2.1). Participants were considered to be “trained” if their maximal oxygen 
consumption (VO2max) was above average, ≥45 ml/kg/min for females and ≥50 ml/kg/min for 
males and if they cycled for 60 minutes or more at least 3 times per week. Recruits who were 
habitual consumers of dark chocolate (>40g/day, 5x/week) and those who supplemented with 
beetroot juice or other exogenous forms of nitrate were excluded. Participant characteristics are 
shown in Table 3.1 of the results. 
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Figure 2.1. Diagram of participant recruitment  
2.3 General Methodology  
 This study was approved by the University of Saskatchewan Biomedical Research Ethics Board 
(BIO ID 189). Participants made a total of 5 visits to the exercise physiology lab at the 
University of Regina School of Kinesiology and Health Sciences.  During the first lab visit, 
informed consent was obtained and participants filled out the Get Active Questionnaire 
(Appendix A) (Canadian Society for Exercise Physiology, 2017) to ensure they could safely 
participate in physical activity. Participant demographic information (height, weight, age) was 
then collected.  Briefly, the protocols for height and weight were as follows. Height was 
measured using a stadiometer (Tanita®).  Participants stood in sock feet with their heels together 
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and against the wall.  The flat measuring ledge of the stadiometer was then lowered to the 
participants head, depressing the hair to lie flat on the head. Participants were instructed to take a 
deep breath and height was measured to the nearest 0.1cm. Weight was measured using a digital 
scale (Health O Meter®).  Participants stood in sock feet and minimal clothing.  Weight was 
measured to the nearest 0.1kg.  Following the collection of consent and demographic 
information, participants underwent an incremental exercise test on a stationary bike (either their 
own affixed to a trainer or a Velotron®) in order to determine their maximal oxygen uptake in 
normoxia (VO2max) and eligibility for the study.  Participants were instructed to maintain their 
normal training regime over the course of the study.  
    Participants returned a minimum of one week later for a second incremental exercise test to 
determine VO2max at a simulated altitude of 2500 m (15% O2), achieved using a normobaric 
altitude chamber.  A power output corresponding to 50% maximal power output achieved during 
the incremental test completed at simulated altitude (approximating about 65% VO2max) was 
deemed the workload for testing sessions. This power output was chosen to replicate the 
intensity that amateur athletes might cycle at during a road race and to ensure excessive fatigue 
did not impact the participant’s ability to complete the TT (Lucia et al., 2000; Vogt et al., 2006). 
On the third visit, participants were familiarized with the exercise protocol used in the testing 
sessions (i.e. 90 minutes at 50% power output achieved in visit 2 followed by a 10 km time trial) 
at hypoxia (15% O2).  After visit 3, participants were randomly assigned to consume either DC  
or a similarly flavored control substance (CON)  Participants supplemented with 60 g twice per 
day (morning and evening) for 14 days of either DC or CON.   On the 15th day, participants 
arrived to the lab in the morning after an overnight (10 hour) fast. Fasted measures of plasma 
lactate and glucose were measured via finger prick blood samples. Following fasted measure, 
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120 g of either DC or CON chocolate were consumed. This dose of chocolate was used to 
maximize polyphenol levels in the body prior to testing session.  A dose of 120g of dark 
chocolate per day is greater than used by Patel et al. (2015), Sudarma et al. (2011), and Faridi et 
al. (2008), all of whom found favorable results on performance, serum nitric oxide, and 
endothelium function, respectively. The participants cycled at a simulated altitude of 2500m 
(15% O2), achieved using a normobaric hypoxic chamber, at an intensity of 50% of workload 
achieved in visit 2 for 90 minutes. Blood lactate and glucose were collected via finger prick at 15 
and 30 minutes and every 30 minutes thereafter.  Expired air was collected for 1 minute every 15 
minutes for analysis of VO2, VCO2, and respiratory exchange ratio (RER). Immediately 
following completion of the 90 minutes at steady state, participants began a 10 km time trial 
(TT), which they were instructed to complete as quickly as possible. Oxygen levels of the 
chamber were monitored using a built-in O2 monitor and levels were maintained between 14.7% 
and 15.1% O2. Oxygenation status was measured via near-infrared spectroscopy (Artinis®) 
during exercise at the vastus lateralis (Portamon®) and at the cerebral lobe (Portalite®). These 
sites were chosen to be measured in order to be able to compare to the current body of literature, 
as the vastus lateralis is the most common site of NIRS measurement.  Additionally, the muscle 
belly of the vastus lateralis is easily visible on a trained individual, allowing for greater precision 
of probe placement. Immediately following the TT, blood glucose and lactate were measured 
again while the participant engaged in a self-selected active recovery.  Following a two-week 
washout period, participants began 14 days of supplementation under the opposite treatment (DC 
or CON) and the same exercise performance testing for a double-blind, counterbalanced, 
































































































































































































































































































































































































































































































































































































              Dark Chocolate                                                 Placebo 
                   
Ingredients: cocoa mass, sugar, cocoa butter,                   Ingredients: (sugar, vegetable oils, skim milk powder,  
soy lecithin, natural vanilla flavoring                               alkalized cocoa, cocoa, glyceryl lacto esters of fatty acids,  
                                                                                           soy lecithin 
2.4 Supplement 
Participants consumed 60g of either 72% dark chocolate (Belcolade Premium Belgium 
Chocolate, Erembodegem, Belgium) or a similarly flavored control (Merckens, Cumberland 
USA) twice per day for 14 days prior to all experimental testing.    The control chocolate 
contained no cocoa butter or cocoa liquor but used alkalized cocoa for coloring. This alkalization 
process reduces the antioxidant potential and polyphenol content, leaving the control essentially 
void of polyphenols (Miller et al., 2008).  The DC condition contained 107mg epicatechin, 30mg 
catechin, and 84mg procyanidin per daily serving . See figure 2.3 for detailed nutritional 












Figure 2.3. Nutritional information of supplement. 
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2.5 Procedures 
2.5.1 Incremental Exercise Test  
 In order to assess the aerobic capacity of participants and determine their eligibility of the study, 
participants underwent an incremental exercise test (VO2max) at normoxia (20.93% O2) on their 
first visit to the lab.  Participants pedaled on a stationary bike (either their own affixed to a 
trainer or a Velotron®).  10 minutes of self-selected warm-up was provided, and after 8 minutes 
a mask to collected expired gases was fitted to their head.  After the 10 minutes of warm up, 
resistance was increased by 20 watts from their self-selected warm up power. Resistance was 
increased by 30 watts every 3 minutes thereafter until participants could no longer maintain 
cadence above 70 RPM or volitional fatigue. Five participants did not reach the required VO2max 
(50 ml/kg/min for males; 45ml/kg/min for females) and thus were excluded from the study.  On 
the second visit to the lab, participants underwent the same test at a simulated altitude of 2500m 
(15% O2). Subsequent exercise tests were completed at 50% power output achieved in the 
incremental exercise test done at hypoxia. 
2.5.2 Measures of physical performance 
 A 10km TT was used as a measure of physical performance.  The TT was completed on a 
stationary cycle (either their own bike affixed to a trainer or a Velotron®) immediately after 90 
minutes of submaximal cycling.  Participants were permitted to manipulate gearing and cadence 
as required throughout the TT. Participants were permitted to see the distance covered 
throughout but were blinded to the time elapsed.  
2.5.3 Metabolic measures 
 
 Plasma glucose and lactate were assessed via finger prick blood samples upon fasted arrival to 
the lab and at 15, 30, 60, and 90 minutes during steady state, as well as immediately following 
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completion of the TT. Prior to data collection, the metabolic cart (Parvo Medics) was calibrated 
according to manufacturer’s specifications. Expired air was collected at for 1 minute at 15, 30, 
45, 60, 75, and 90 minutes during steady state exercise.  
     The measurement of expired air was used to determine the O2 cost of exercise as well as the 
primary substrate being metabolized. The values for O2 consumed and CO2 produced were 
applied to equations described by Jeukendrup and Wallis (2005) to determine the primary 
substrate being metabolized. Carbohydrate and fat oxidation (in g/min) were calculated using the 
following respective equations:  
𝐶𝐻𝑂𝑜𝑥 = 4.210 ∗ 𝑉𝐶𝑂2 − 2.962 ∗ 𝑉𝑂2 
𝐹𝐴𝑇𝑜𝑥 = 1.695 ∗ 𝑉𝑂2 − 1.701 ∗ 𝑉𝐶𝑂2 
The knowledge of the primary substrate being metabolized also lends itself to inferring the 
metabolic efficiency of exercise, as a more efficient metabolic system will metabolize a greater 
percentage of lipids and thus spare stored glycogen, delaying fatigue (Patel et al., 2015).  This is 
especially important in endurance athletes because depletion of glycogen is large contributor to 
fatigue (Ørtenblad et al., 2013), so glycogen sparing by way of lipid metabolism will allow the 
athlete to maintain a given exercise intensity for longer and preserve glycogen stores to produce 
a strong sprint in the final minutes of exercise.  
2.5.4 Tissue Oxygenation 
 
The use of the NIRS system to measure tissue oxygenation is based on the Beer-Lambert Law, 
which describes the relationship between light absorption and chromophore concentration 
(Simonson & Piantadosi, 1996). NIRS detects changes in light absorption in hemoglobin, 
myoglobin, and cytochrome oxidase. Although NIRS measures changes in all three of the 
aforementioned chromophores, the light attenuation due to myoglobin and cytochrome oxidase is 
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minimal compared to that of hemoglobin (Kennedy et al., 2006).  Oxygenated hemoglobin 
absorbs light at 850nm while deoxygenated hemoglobin absorbs light at 760nm. Thus, by 
measuring the difference in the amount of light emitted into a tissue at 850 and 760nm compared 
to that which is absorbed provides information on the concentration of oxygenated and 
deoxygenated hemoglobin, expressed as optical density units (Kennedy et al., 2006). Tissue 
oxygenation of the cerebral cortex (Portalite) and the knee extensors (Portamon) was measured 
via NIRS.  Participants were instructed to maximally extend the knee of their dominant leg 
without any load to allow palpation of the muscle belly of the vastus lateralis. One probe was 
placed on the belly of the vastus lateralis, approximately 15 cm above the proximal border of the 
patella and 5 cm lateral to the midline of the thigh, parallel to the long axis of the muscle in 
accordance with Subudhi et al. (2007). Kennedy et al. (2006) described differences in muscle 
oxygenation within the vastus lateralis depending on probe placement (i.e. greater muscle 
oxygenation at proximal areas of the vastus lateralis relative to the distal portion) therefore, 
probes were placed within 2 cm on visit 5 relative to placement on visit 4, ensuring any changes 
measured were due to physiologic changes rather than probe placement.  Probes were secured to 
the leg using a dark coloured generic elastic sleeve to ensure the probe did not move and to 
shield the device from ambient light.  A second probe was positioned on the prefrontal cortex on 
the right side, ~2 cm above the eyebrow as laterally as possible.  The cerebral probe was held in 
place using a dark coloured elastic headband to minimize probe movement and block ambient 
light.  In the case of excessive hair growth impeding the signal on the quadriceps, the skin was 
shaved to eliminate the signal interference. Micromolar changes in tissue oxygenation and 
deoxygenation were measured throughout the duration of exercise in visits 4 and 5. Total 
hemoglobin was calculated as the sum of oxygenated and deoxygenated hemoglobin and used as 
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a measure of site-specific blood flow. Prior to exercise, a measurement was taken while the 
participant sat quietly on the bicycle to provide a baseline measurement, which all measurements 
during exercise would be compared to (arbitrarily defined as 0M). A leg-cuff induced ischemia 
post exercise to obtain a low-oxygen reference point was not used, as Chance et al. (1992) 
showed minimal additional desaturation during supra-systolic cuff occlusion of the vastus 
lateralis muscle immediately following a maximal exercise test. As discrepancies in muscle 
oxygenation of the vastus lateralis have been observed based on diode placement (Kennedy et 
al., 2006), great care was taken to ensure analogous placement of the probe on repeat visits.  
 
2.6 Sample Size and Analysis 
 
A sample size of 12 was chosen based on an effect size of 0.67 for our primary outcome, time 
trial performance. Sample size was calculated using G*Power app (© Franz Faul, Edgar 
Erdfelder, Albert-Georg Lang, and Axel Buchner, 2006, 2009) based on a beetroot study by 
Muggeridge and colleagues (2013) (Baseline: 1716 ± 17 s; BR: 1664 ± 14 s, P = 0.006, CI 15.3 – 
66 s; effect size d=0.67), a 95% confidence interval, and a power of 80%.  Similar studies 
(Masschelein et al., 2012; Muggeridge et al., 2014; Patel et al. 2015) have found sample sizes of 
9-15 participants to be effective in detecting a significant difference between groups. By using a 
cross-over design, inter-individual variability can be eliminated, increasing the power and 
precision of the study and protecting against type II error.  By including a familiarization trial 
prior to experimental trials, any learning effect can be reduced and the validity of the measures is 
increased (Laursen et al., 2003). Experimental trials under opposite conditions occurred one 
month apart, ensuring that any female participants were in a similar phase of their menstrual 
cycle to eliminate any hormonal effects of performance.  This timeline means that a two-week 
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washout period between conditions was respected.  The half-life of flavonoids ranges from 2-28 
hours (Manach & Donovan, 2004), so a 2-week washout period is sufficient.  All tests were 
conducted in the morning following a minimum 10-hour fast to eliminate diet and circadian 
rhythms as confounding factors.  
     The primary hypothesis was tested using a one-way repeated measures Analysis of Variance 
to assess TT performance. The secondary hypotheses were assessed using two-factor (2x6) 
repeated measures Analysis of Variance investigating the interaction of supplement and time to 
determine if there were differences in plasma glucose, plasma lactate, oxygen consumption, 
carbon dioxide production, and substrate oxidation. A 2x7 design was used to assess cerebral and 
muscular oxygenation at different time points. In the case that sphericity was violated while 
running the interactions, a Greenhouse-Geisser adjustment was used to correct the degrees of 
freedom. By using this correction factor, we are able to protect against the increased risk of Type 
I error that would arise if sphericity was violated. Box plots were used to determine whether 
there were any outliers in the data. NIRS data showed many outliers (~50-60%) while other 
measures showed less (~15-25%) If an outlier was present, the datum was removed.  In the case 
that removal of outliers decreased the sample size significantly, the outlying data points were 
removed and replaced with the mean of the group. Measures of plasma glucose and lactate were 
broken into 6 different time points: pre-exercise, 15, 30, 60, and 90 minutes during steady state, 
and immediately following the time trial. Gas analysis (VO2 carbon dioxide production, and 
substrate oxidation) was also broken into 6 different collection points: 15, 30, 45, 60, 75, and 90 
minutes during steady state exercise.  When main effects of time or interactions between 
condition and time were detected from the two-way ANOVA, a Tukey’s HSD post hoc test was 
used to assess differences between pairs of means.  An alpha of 0.05 was considered statistically 
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significant. Results were analyzed using JASP statistical software, version 0.10.2 (2013-2019, 
University of Amsterdam). Results are expressed as means and standard deviations, except in 
figures, where standard error of the mean was used for clarity (i.e. to prevent distortion of the 
figures). 
2.7 Dietary and Training Control  
During the experimental trial, participants were instructed to keep their training and dietary 
habits constant.  However, in the two days leading up to visit 4 (i.e. days 13 and 14 of 
supplementation), participants were asked to refrain from foods that are high in polyphenols, 
such as berries, dark leafy greens, coffee, and tea.  Participants were asked to keep a food log 
during these two days and were instructed to keep the food log in order to replicate it in the two 





















Chapter 3: Results 
 
Seventeen athletes consented to take part in the study.  Of these, 5 did not meet the inclusionary 
criteria for VO2max, leaving 12 athletes (n=2 females) to participate in the study. All athletes 
came from a background of cycling, triathlon, or duathlon. Participants were trained athletes who 
cycled at least 3 times per week in bouts of 60 minutes or more, had above average VO2max 
scores (>50ml/kg/min for males and >45 ml/kg/min for females), and were not regular 
consumers of dark chocolate (<50g/day, 5 days/week).  Data is presented as mean  standard 
deviation unless specified as otherwise, in which case standard error of the mean was used to 
preserve figure quality. Demographic information is shown in table 3.1 below. 
 
Table 3.1. Participant Characteristics. Participant characteristics are displayed in means  
standard deviations. VO2 max = maximum oxygen consumption. 
 
3.1 Time Trial 
There was no statistical difference in time trial performance between the two conditions, F(1, 
10)=0.91, p=0.77. The mean time to complete the time trial under the dark chocolate condition 
was 19.04 (±2.16) minutes and the mean time to completion under the placebo condition was 
19.21 (±1.96) minutes.   
3.2 Blood Parameters 
Glucose: The assumption of sphericity was not met (p=.009) for time effects so a Greenhouse-
Geiser epsilon was used to adjust the degrees of freedom. There was a significant main effect of 
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supplement on plasma glucose F(1, 10)=6.020,  p=.034, with the DC maintaining blood glucose 
at a higher level than the placebo (5.5±0.5 mmol vs 5.3± 0.9 mmol/L for dark chocolate versus 
placebo, respectively). There were also significant main effects of time on plasma glucose, 
F(2.482, 24.816)=14.714, p<.001. The 60-minute time point was significantly higher than fasted 
(p=.013) and 15 minute (p=.028) measurements, while the post TT measurement was 
significantly higher from fasted (p=.004), 15 minute (p=.011), and 30 minute (p=.013) time 
points. No statistically significant interaction between chocolate and time on blood glucose was 










Figure 3.1. Blood glucose values observed at different time points. * denotes significantly 
different from post TT measurement, p<.05.  + denotes different from the 60 min measurement, 
p<.05. Data are displayed as mean  standard error of the mean. 
 
Lactate: The assumption of sphericity was not met (p<.001) for supplement x time interaction so 
a Greenhouse-Geiser epsilon was used to adjust the degrees of freedom. There were no 
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significant main effects of supplement on blood lactate, F(1, 11) =.393, p=.544. A significant 
main effect of time on blood lactate was found, F(1.450, 15.974)=30.649, p<.001. Fasted 
measures were significantly lower than all other time points (p<.05). Post TT measurements 
were significantly higher than all other time points, except at the 90-minute time point (p<.01). A 
significant interaction between supplement and time was also observed, F(1.528, 16.811)= 
4.955, p=.027. The DC condition resulted in significantly lower lactate levels compared to the 
placebo following the TT, p=.009 (7.7 mmol/L vs. 10.0 mmol/L). 










Figure 3.2. Supplement x time interaction on blood lactate.  * signifies significantly different 
from placebo, p<.05. Data are displayed as mean  standard error of the mean.  
 
3.3 Gas analysis 
In analyses where assumption of sphericity was violated based on Mauchly’s test of sphericity, a 
Greenhouse-Geiser epsilon was used to adjust the degrees of freedom. 
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VO2:  There was no significant main effect of supplement on VO2, (F(1, 9)=.936, p=.359). No 
significant main effect was found for time (F(5, 45)=6.439, p=.454). There was no supplement x 
time interaction (F(5, 45)=7.324, p=.387). Results are depicted in figure 3.3. 
 
Figure 3.3. Oxygen consumption (VO2) observed at different time points. Data are displayed as 
mean  standard error of the mean. No significant differences were found across the analysis.  
 
RER: There was no significant main effect of supplement on RER, (F(1, 8)=2.513, p=.152). No 
significant main effect was found for time (F(1.980, 15.839)=.372, p=.639). There was no 
supplement x time interaction (F(5, 40)=1.293, p=.286).  
Carbohydrate and Fat Oxidation: No significant effects of supplement on carbohydrate or fat 
oxidation were found, (F (1, 9) =2.071, p=.184 and F (1, 9) =.577, p=.467, respectively). There 
were no significant effects of time on carbohydrate or fat oxidation, (F (5, 45) =.071, p=.661 and 
F (2.380, 21.417) =.470, p=.664, respectively). There was also no significant interaction of 
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supplement and time on carbohydrate or fat oxidation, (F (5, 45) =.804, p=.553 and F(5, 
45)=.774, p=.573, respectively).  Results are depicted in figures 3.4 and 3.5 respectively.  
 
Figure 3.4. Carbohydrate oxidation at different time points in g/min. Data are displayed as mean 
 standard error of the mean. No significant differences were found. 
 
 
































Figure 3.5. Fat oxidation at different time points in g/min.  Data are displayed as mean  
standard error of the mean.  No significant differences were found. 
 
3.4 Near Infrared Spectroscopy 
 
3.4.1 Vastus Lateralis 
 Oxygenated hemoglobin: There was no significant effect of supplement on the amount of 
oxygenated hemoglobin, (F (1, 11) =3.389, p=.093), nor was there a significant interaction of 
supplement and time, (F (1.828, 20.112) =.409, p=.652).  There was a significant main effect of 
time on oxygenated hemoglobin, (F (2.127, 21.272) =8.451, p=.002). The 15-minute 
measurement was significantly lower than at 90 minutes (p=0.020).  Measurements at 30 minutes 
were significantly lower than at 60 minutes (p=.018), 75 minutes (p=.007), and 90 minutes 
(p=.011). Measurements at 45 minutes were significantly lower from those at 60 minutes 
(p=.024), 75 minutes (p=.022) and 90 minutes (p=.011). Results are depicted in figure 3.6.  





























Figure 3.6. The amount of oxygenated hemoglobin in the vastus lateralis of the dominant leg 
compared to a baseline measure, as measured by near infrared spectroscopy. * signifies 
significantly different from 15 minute, + signifies significantly different from 30 minute, and # 
signifies significantly different from 45 minute (p<.05). Data are presented as mean  standard 
error of the mean 
 
Deoxygenated hemoglobin There was no effect of supplement or interaction of supplement and 
time on deoxygenated hemoglobin, (F (1, 10) =1.510, p=.247 and F(3.014, 30.139)=1.764, 
p=.175, respectively). There was an effect of time on deoxygenated hemoglobin, F(2.753, 
27.528)=9.069 p<.001. 15-minute measurements were significantly lower than 30 (p=.001), 45 





Figure 3.7.  The amount of deoxygenated hemoglobin in the vastus lateralis of the dominant leg 
compared to a baseline measure, as measured by near infrared spectroscopy. * signifies 
significantly different from 15-minute, p<.05. Data are presented as mean  standard error of the 
mean. 
 
Total hemoglobin: There was no effect of supplement or interaction of supplement and time on 
total hemoglobin, (F (1, 7) =0.967, p=.358 and F (2.173, 15.213) =.345, p=.731, respectively). 
There was a significant effect of time on total hemoglobin in the vastus lateralis, (F(1.718, 
12.025)=16.421, p<.001). 15-minute measurements were significantly lower than 45 (p=.008), 
60 (p=.007),75 (p=.007), and 90 minutes (p=.020).  30-minute measurements were significantly 
lower than time points 45 (p=.038), 60 (p=.017), 75 (p=.017), and 90 minutes (p=.040). Results 




Figure 3.8. The total amount of hemoglobin in the vastus lateralis of the dominant leg compared 
to a baseline measure, as measured by near infrared spectroscopy. * signifies significantly 
different from 15 minute and + signifies significantly different from 30-minute, p<.05. Data are 
presented as mean  standard error of the mean. 
 
3.4.2 Cerebral Lobe 
Oxygenated hemoglobin: There was no significant effect of supplement on the amount of 
oxygenated hemoglobin, (F (1, 8)= 4.404, p=.069), nor was there a significant interaction of 
supplement and time, (F(1.423, 11.383)=.68, p=.482) in the cerebral lobe. There was however a 
significant effect of time on the amount of oxygenated hemoglobin (F(1.345, 10.757)=10.167, 
p=.006).  15-minute measurements were lower than 45 (p=.016), 60 (p<.001), 75 (p=.019), and 
90 minutes (p=.043). Results are depicted in figure 3.9. 
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Figure 3.9. The amount of oxygenated hemoglobin in the right cerebral lobe relative to baseline 
measures, as measured by near infrared spectroscopy.  * signifies significantly different from 15 
minute for oxygenated hemoglobin, p<.05. Data are presented as mean  standard error of the 
mean.  
 
Deoxygenated hemoglobin: There was no significant effect of supplement on the amount of 
deoxygenated hemoglobin, (F (1, 9) =.262, p=.621), nor was there a significant interaction of 
supplement and time, (F(1.797, 16.169)=.351, p=.687).  There was a significant main effect of 
time on deoxygenated hemoglobin, (F (1.465, 11.723) =10.765, p=.004). The amount of 
deoxygenated hemoglobin was significantly lower at 15 minutes than 45 minutes (p=.017). 
Results are depicted in figure 3.10. 
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Figure 3.10. The amount of deoxygenated hemoglobin in the right cerebral lobe relative to 
baseline measures, as measured by near infrared spectroscopy.  * Signifies significantly different 
from 15 minutes, p<.05. Data are presented as mean  standard error of the mean. 
 
Total hemoglobin: There was no significant effect of supplement on the total amount of 
hemoglobin, (F (1, 9) =.960, p=.353), nor was there a significant interaction of supplement and 
time, (F(1.714, 15.430)=.467, p=.606).  There was a significant main effect of time on total 
hemoglobin, (F (1.289, 10.314) =8.366, p=.012). 15-minute measurements were significantly 




Figure 3.11. The total amount of hemoglobin in the right cerebral lobe relative to baseline 
measures, as measured by near infrared spectroscopy.  * signifies significantly different from 15-
minute measurements, p<.05. Data are presented as mean  standard error of the mean. 
 
3.5 Adverse Effects 
Two participants reported GI distress while consuming DC during the 2-week supplementation 
period. These symptoms included abdominal pain, diarrhea, and general “upset stomach”. One 
reported mild symptoms that did not interfere with consumption of the supplement or with daily 
activities. The second participant, however, reported more severe symptoms that limited the 
amount of the supplement that could be consumed as well as interfered with daily activities. This 
participant consumed approximately 50% of the required dose and data from this participant was 
treated as per usual, without any outlying data being removed. No adverse effects were reported 




Eleven participants reported a compliance of 100% for the combined 4 weeks of 
supplementation.  One participant reported 60% compliance rate for the DC condition due to GI 
distress and 100% compliance for the placebo. 
3.7 Sub Analyses  
 
Past research has demonstrated an increase in cerebrovascular function in males while lesser 
effects were observed in females (Fan et al., 2019).  To assess potential sex differences in the 
current study, a sub analysis was run on the male participants only (n=10).  No difference was 
found in TT performance between conditions, (F(1,8)=.014, p=.908).  Similarly, no differences 



















Chapter 4: Discussion 
 
     The results of the current study demonstrate that two weeks of DC supplementation have no 
effect on TT performance at simulated altitude in trained cyclists. DC did, however, improve the 
maintenance of blood glucose throughout exercise and decrease the accumulation of lactate 
following the TT. To the author’s knowledge, this is the first study to examine the effects of dark 
chocolate on performance measures at simulated altitude. This research is important, as many 
cycling races such as the Tour de France and Giro d’Italia have mountain stages that reach as 
high as 2600m.  Many riders do not have the resources to acclimatize prior to a race at high 
altitude, and thus must rely on other methods to properly prepare for the reduced oxygen partial 
pressure at altitude.  We hypothesized that 2 weeks of dark chocolate supplementation with 60g 
twice daily would improve 10km time trial performance, enhance oxygenation of the vastus 
lateralis and cerebral lobe, improve glucose and lactate handling, decrease the oxygen cost of 
submaximal exercise, and decrease the reliance on carbohydrate metabolism during cycling at a 
simulated altitude of 2500m.  
4.1 Time Trial Performance  
     The results of the current study suggest that dark chocolate does not affect 10km TT 
performance at a simulated altitude of 2500m in trained cyclists, which is in contrast to our 
research hypothesis.  This is, in agreement with the findings of Stellingwerff and colleagues 
(2013), who found no improvement in 15-minute time trial performance completed after a 2.5-
hour bout of steady-state exercise completed at 43.5% VO2peak at normoxia  following 
consumption of dark chocolate.  The authors speculated that a greater exercise intensity before 
the time trial may have elicited greater performance enhancements due to an increased reliance 
on carbohydrates at higher intensities.   Likewise, Peschek and colleagues (2013) observed no 
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increase in running time trial performance the day after a damage-inducing bout of downhill 
running after consuming a beverage fortified with additional cocoa. Other studies have suggested 
an improvement in exercise performance or metabolic markers when dark chocolate is consumed 
before exercise. For example, Patel et al. (2015) found that 40g of dark chocolate for 14 days 
before exercise testing resulted in increased performance in a 2-minute time trial as well as an 
increased gas exchange threshold.  Allgrove et al. (2011) found that two weeks of 
supplementation with 40g of dark chocolate twice daily did not improve time to exhaustion but 
resulted in lower resting and post-exercise plasma levels of the oxidative stress markers F2-
isoprostanes and oxidized LDL. Differences in findings in the literature could be related to the 
duration of the TT performed.  Patel et al (2015) found that DC enhanced TT performance for a 
2-minute TT, while Peschek et al. (2013) and Stellingwerff et al. (2013) used protocols that 
lasted 15-20 minutes.  Allgrove et al. (2011) used a TTE protocol which lasted a mean of 6.6 
minutes.  Thus, differences in findings could be related to the duration of the trial and the relative 
contribution of the aerobic and anaerobic energy systems.  A second potential explanation could 
be due to differences in control substances used.  The current study used a chocolate flavored 
molding wafer containing no cocoa liquor or cocoa butter, while Patel and colleagues (2015) 
used a white chocolate.  Other researchers (Allgrove et al., 2011; Stellingwerff et al., 2013; 
Pescheck et al., 2013) used a control chocolate that had similar appearance but lacked 
polyphenols. 
     Our results are in contrast to other studies using different nutritional supplements that are 
promoted for increasing nitric oxide production and therefore blood flow during exercise.  For 
example, Masschelein et al. (2012) found that supplementation with ~500ml of nitrate-rich 
beetroot juice for 2 weeks increased cycling time to exhaustion completed at 11% O2.  
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Muggeridge et al. (2013) also found an improvement in 16.1km TT performance when athletes 
supplemented with 70 ml of concentrated nitrate-rich beetroot juice three hours before exercise 
testing completed at a simulated altitude of 2500m (15% O2). This study may have resulted in 
differing results compared to those that utilized beetroot juice due to the mechanism by which 
each of the supplements work.  Beetroot juice acts as an exogenous source of nitrate for the body 
to break down to NO.  DC acts as a source of polyphenols, increasing the production of NO as 
well as the reuptake.  However, if individuals do not have the necessary influx of dietary nitrates, 
these mechanisms may not be effective.  
4.2 Metabolic Analyses 
     We hypothesized that dark chocolate supplementation would result in superior exercise 
metabolism, evidenced by improved glucose and lactate handling, decreased VO2 for a given 
workload, and an increased reliance on fats for energy. A significant interaction between 
supplement condition and time was observed for blood lactate concentration.  When post hoc 
testing was conducted, decreased blood lactate following the time trial in the dark chocolate 
condition  (8.6±3.8 vs. 10.0±4.6 mmol/L p=0.009) was observed.  We found no differences in 
lactate levels between conditions before the time trial (i.e. during the constant-load cycling). This 
is similar to Patel and colleagues (2015) who reported no differences in blood lactate 
concentration during a 20-minute moderate intensity cycle following 2-weeks of 40g/day dark 
chocolate supplementation. Similar results were found by Davison et al. (2012), who reported no 
effect of an acute dose of 100g of 70% dark chocolate on blood lactate at rest, immediately post 
exercise, or one-hour post exercise. Interestingly, Fraga et al. (2005) observed an increase in 
resting lactate measures in healthy, young soccer players following the consumption of dark 
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chocolate compared to white chocolate consumption. The authors did not provide speculation 
into the reasons that this may have occurred.  
     Main effects of both supplement and time were observed for blood glucose concentration, 
showing increased blood glucose values throughout the exercise (time effect) and showing 
improved maintenance of blood glucose throughout the experimental trial under the dark 
chocolate condition (5.9±0.5 vs. 5.6±0.5 mmol/L; p=0.03).  These results are consistent with 
those found by Stellingwerff et al. (2013) as well as Davison et al. (2012). Stellingwerff and 
colleagues (2013) observed that the consumption of DC augmented blood glucose concentrations 
during low-intensity exercise compared with a nearly iso-caloric and iso- carbohydrate cocoa-
deplete control. The increased plasma glucose coincided with high concentrations of polyphenol 
and theobromine found in DC that could potentially attenuate muscle glucose uptake. It was 
suggested that the augmented plasma glucose was due primarily to a decreased rate of glucose 
uptake paired with an unaltered rate of appearance of glucose. Animal studies have shown a 
competitive inhibition of insulin-mediated GLUT-4 transporters by some classes of polyphenols 
(Strobel et al., 2005).  However, the authors noted that exercise-mediated GLUT-4 translocation 
mechanisms would be at work during this trial rather than insulin-mediated effects; therefore, the 
mechanisms behind differences in glucose uptake are unknown.  
     Davison et al. (2012) found that DC consumption 2 h before an acute bout of prolonged 
exercise (2.5 h at 60% VO2max) resulted in significantly higher pre-exercise plasma insulin 
concentrations as well as smaller perturbations in plasma glucose concentration compared with 
the consumption of a closely matched control.  It remains unclear whether alterations in the 
insulin and glucose responses are due to alterations in the insulin response, glucose handling, 
interference of glucose uptake, the action of insulinogenic amino acids in the cocoa, or some 
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other mechanisms. Differences in the current study are possibly due to the differences in 
macronutrients between the conditions.  The dark chocolate condition contains higher levels of 
fat and protein which could lead to better maintenance of blood glucose, while the control 
contained higher levels of carbohydrate.   
     There were no effects of either supplement or time on gas analysis, including oxygen uptake 
during steady-state exercise and carbohydrate or fat oxidation (calculated using VO2 and VCO2 
values).  This is in agreement with findings by Patel et al. (2015), who observed no differences in 
VO2 or RER after supplementation with dark chocolate but did observe a difference in the gas 
exchange threshold. These results are in contrast to those found by Allgrove et al. (2011), who 
observed a lower RER during prolonged exercise following two weeks of dark chocolate 
supplementation suggesting a greater proportion of energy coming from fatty acid oxidation. The 
differing results could be due to the time frame in which the DC was consumed prior to exercise. 
The Allgrove lab (2011) had their participants consume the chocolate two hours prior to 
exercise, while in the current study the DC was consumed about 30 minutes prior to exercise.  
This difference in time could result in differential absorption rates and thus actions of the 
caffeine and theobromine in the chocolate, both of which can independently increase lipolysis 
(Durham et al., 2000).  Epicatechin acts synergistically with caffeine and theobromine to further 
enhance fat metabolism (Dulloo et al., 2000).  Differences could also be due to the exercise 
protocol, as Allgrove et al. (2011) had participants sprint at 90% VO2max for 10 seconds every 
10 minutes during the 90-minute ride at 60% VO2max, while the current maintained a steady 
state of 60% VO2max for the full duration (90 minutes). 
      In contrast to our results with dark chocolate, supplementation with other nutrients that are 
reported to enhance nitric oxide production and blood flow (i.e. beetroot juice) was effective for 
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decreasing VO2 at submaximal intensities at altitude (Muggeridge et al. 2013), whereas the 
current study found no change in oxygen uptake at submaximal intensities.  These discrepancies 
in findings could be due to the mechanisms by which each of DC and beetroot juice act, as 
beetroot juice directly provides exogenous nitrates to be converted to nitrites and then to NO, 
while DC increases the rate at which the body can convert nitrites to NO.  Therefore, if the body 
is already producing the maximal amount of NO relative to the amount of nitrates and nitrites 
available, the effects of the DC would be irrelevant.   
     The results for blood glucose and lactate partially support our hypotheses that the dark 
chocolate would improve glucose homeostasis and lactate handling. This is an important finding, 
as a maintenance of blood glucose and decreased lactate accumulation during prolonged exercise 
may reduce fatigue by decreasing ratings of perceived exertion, low blood glucose levels, and 
acidosis, permitting the athlete to maintain a higher intensity for longer.  However, gas analyses 
refuted our hypothesis that dark chocolate would lead to decreased oxygen consumption as well 
as an increased reliance on fatty acids for ATP generation and thus glycogen sparing.   
4.3 Oxygenation of the Brain and Vastus Lateralis  
     Dark chocolate does not affect the oxygenation status of the cerebral lobe or the vastus 
lateralis muscle during exercise, as measured by near-infrared spectroscopy.  Results showed no 
effect of the supplement on oxygenated, deoxygenated, or total hemoglobin at either of the sites 
measured.  However, there was an effect of time on all measures at both the vastus lateralis and 
cerebral lobe, indicating an increase in oxygen extraction as well as blood flow, as would be 
expected during a prolonged exercise test.  These results indicate the tool utilized to measure 
oxygenation was valid. These results are in agreement with Decroix et al. (2016), who found 
supplementation with cocoa flavanols to increase brain oxygenation at rest but not during 
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exercise. The researchers found that cocoa flavanols had no additive effect on the exercise-
induced cognitive enhancement and the associated increased cerebral oxygenation and perfusion. 
Masschelein and colleagues (2011) also found that supplementation with nitrate (in the form of 
beetroot juice) did not affect cerebral oxygenation status or acute mountain sickness. However, 
the same group observed increased oxygenation in the vastus lateralis at both submaximal and 
maximal exercise at simulated altitude (11% O2), which is contrary to the results of the current 
study. Once again, differences in findings could be due to the body optimally converting all of 
the accessible nitrites to NO, and thus increasing the bioavailability further through the use of 
DC does not show an effect, whereas by directly ingesting exogenous nitrates, the body is 
provided additional substrate to convert to NO, thus inducing endothelium-dependent 
vasodilation. 
     An interesting finding in the current study is that of the oxygenation status of the brain during 
the time trial.  Often we see an increase in blood flow to the brain directly related to arterial CO2 
tension (Ide & Secher, 2000). However, the current study showed a decrease in cerebral 
oxygenation during the 10km TT, although this did not reach significance.  One speculation as to 
the mechanisms behind this has to do with our significant lactate findings.  As the muscle 
increases lactate production with increasing exercise intensity, bicarbonate enters the cell in 
order to buffer the increased lactate.  For each mmol of lactic acid buffered, 1mmol of additional 
CO2 is generated (Péronnet & Aguilaniu, 2006). Due to the rapid rate of diffusion of CO2 across 
the blood brain barrier, one might expect this CO2 to alter the pH of the cerebral extracellular 
fluid and thus moderate cerebral vascular resistance to allow for enhanced blood flow.  Due to 
our results showing significantly decreased lactate following the TT in the DC condition 
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compared to the placebo, this decreased lactate could result in decreased CO2 crossing the blood-
brain barrier, leading to a decrease in cerebral vascular vasodilation.  
4.4 Strengths 
     To our knowledge, this is the first study to investigate the effects of dark chocolate on 
exercise performance at altitude. Before this, dark chocolate had only been investigated at 
normoxia, often investigating the effects on blood pressure in a clinical population.  Studies have 
also been done researching the effect of exogenous nitrate (beetroot juice) on exercise 
performance at altitude.  This study is novel in that it combines these two areas, looking at dark 
chocolate on exercise at altitude, measuring not only performance outcomes but also blood flow, 
oxygen extraction, and exercise metabolism. The use of the NIRS system allowed for real-time 
information of the oxygenation status of, and blood flow to both the cerebral lobe and working 
muscles, both sites which are known to contribute to fatigue (Secher et al, 2008; Subudhi et al., 
(2007). 
The research investigating dark chocolate on exercise often does not differentiate between 
trained and recreational athletes.  Through training, the athlete becomes more efficient both 
biomechanically and physiologically (Woo et al., 2006).  As such, trained and untrained 
individuals may respond to the same exercise and nutritional strategies very differently. It is 
important to differentiate between trained and untrained to make the most accurate 
recommendations for every level of training and competition. Using trained athletes is also a 
strength because those who are more trained have less variation in day-to-day exercise 
performance, increasing the validity of the study.   
50 
4.5 Limitations 
A large limitation of the current study was the conditions present inside of the altitude chamber.  
Being an airtight box to maintain oxygen levels, the limited airflow leads to an increase in both 
ambient temperature and relative humidity levels.  The temperature increased by as much as 3 
degrees Celsius and humidity increased as much as 45% over the course of the ~2 hours that 
participants spent in the chamber.  Due to such high temperature and humidity readings, 
excessive sweat measurements impacted the ability of the NIRS probes to read the oxygenation 
status and in some cases caused complete malfunction of the probe. This decreased the number 
of participants we were able to get data from; therefore, increasing the possibility of a Type II 
error, and potentially missing significant differences in cerebral oxygenation status. Although 
this impacted our ability to collect all NIRS data, temperature and humidity were monitored 
every 15 minutes for each participant and environmental conditions for each participant were 
similar for both visits 4 and 5.   
     Participants reported that the amount of chocolate they were required to consume was very 
significant and the palatability of the chocolate decreased significantly over the two weeks of 
supplementation. Some participants reported GI distress after consuming large amounts of the 
dark chocolate consisting of cramping and abdominal pain.  
     Because the hormonal differences between men and women vary significantly, a larger 
proportion of female participants would be required to look at subgroup difference between men 
and women and potential differences within females in different phases of their menstrual cycle. 
Another potential limitation of the current study is that we used RER to infer what was 
happening at the cellular level. However, this could lead to inaccurate interpretations, as a 
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decrease in pH caused by an increase in lactate may result in heightened CO2 levels, confounding 
the RER measurement (Bar et al., 1965).  
4.6 Recommendations for future research 
To determine if dark chocolate could be a viable sport supplement in endurance athletes, it is 
recommended that further research investigate the effects of dark chocolate on performance in 
recreational athletes as well as endurance athletes from different sports and athletes from power-
based sports such as track cycling, bobsleigh, and powerlifting. Current literature investigating 
the effects of exogenous nitrates (i.e. beetroot juice) shows benefits in performance of recreation 
athletes, but not in a trained population (Jonvik et al., 2015).  This may be due to the benefits on 
NO for optimizing endothelial function, as the endothelium of highly trained athletes is likely 
already functioning close to optimally. Also, the impact of NO on mitochondrial biogenesis 
could also explain the differences in impact between trained and untrained/recreational 
individuals, as those who are well trained may see a ceiling effect for mitochondrial biogenesis 
and thus may not see performance benefits due to further increases.    Implications of dark 
chocolate on the anaerobic energy systems will also provide greater knowledge on the benefits of 
dark chocolate across different sports. Due to the high antioxidant content of dark chocolate, 
future research should investigate the effects of dark chocolate on recovery and multi-day 
performances. Assessment of oxygen intake and macronutrient metabolism may also be better 
understood by collecting gasses in a more realistic setting such as on the road using a portable 
indirect calorimetry system. 
     Dark chocolate activates nitric oxide synthase, catalyzing the conversion of nitrite to NO for 
the body to use.  Future research should investigate a combination of exogenous nitrate (beetroot 
juice, sodium nitrate) along with dark chocolate or other flavonoid-rich foods as a method to 
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increase endothelial modulated vasodilation and blood flow. This could be a beneficial 
combination due to their potentially complimentary mechanisms.  Ingestion of exogenous 
nitrates as beetroot juice could lead a greater supply of nitrates and thus a greater concentration 
of nitrite, which DC may then convert to NO in order to see additive effects of the supplements.  
      
4.7 Conclusion 
Although dark chocolate improved glucose handling and decreased lactate levels after a high-
intensity TT completed at a simulated altitude of 2500m, it did not result in improved TT 
performance in trained cyclists.   By maintaining blood glucose and improving lactate handling, 
athletes may find performance benefits in longer, glycogen depleting exercise and routes that 















Allgrove, J., Farrell, E., Gleeson, M., Williamson, G., & Cooper, K. (2011). Regular dark 
chocolate consumption’s reduction of oxidative stress and increase of free-fatty-acid 
mobilization in response to prolonged cycling. International Journal of Sport Nutrition and 
Exercise Metabolism, 21(2), 113-123.  
Anderson, D. E., & Hickey, M. S. (1994). Effects of caffeine on the metabolic and 
catecholamine responses to exercise in 5 and 28 degrees C. Medicine and Science in Sports 
and Exercise, 26(4), 453-458.  
Araujo, Q. R. D., Gattward, J. N., Almoosawi, S., Parada Costa Silva, Maria das Graças 
Conceição, Dantas, Paulo Alfredo De Santana, & Araujo Júnior, Quintino Reis De. (2016). 
Cocoa and human health: From head to foot—a review. Critical Reviews in Food Science 
and Nutrition, 56(1), 1-12.  
Åstrand, P. O., Rodahl, K., Dahl, H. A., & Strømme, S. B. (2003). Textbook of work physiology: 
physiological bases of exercise. Human Kinetics. 
Bar, U., & Blanchaer, M. C. (1965). Glycogen and CO2 production from glucose and lactate by 
red and white skeletal muscle. American Journal of Physiology-Legacy Content, 209(5), 
905-909. 
Bayat, C. E., Fatahi, M., Tabei, A., & Najarzadeh, A. (2014). Antioxidants and muscle damage.  
54 
Beidleman, B. A., Muza, S. R., Fulco, C. S., Cymerman, A., Sawka, M. N., Lewis, S. F., & 
Skrinar, G. S. (2008). Seven intermittent exposures to altitude improves exercise 
performance at 4300 m. Medicine and Science in Sports and Exercise, 40(1), 141.  
Berglund, B., & Hemmingsson, P. (1982). Effects of caffeine ingestion on exercise performance 
at low and high altitudes in cross-country skiers. International Journal of Sports Medicine, 
3(04), 234-236.  
Bergström, J., Hermansen, L., Hultman, E., & Saltin, B. (1967). Diet, muscle glycogen and 
physical performance. Acta Physiologica, 71(2‐3), 140-150.  
Billaut, F., & Smith, K. (2010). Prolonged repeated-sprint ability is related to arterial O2 
desaturation in men. International journal of sports physiology and performance, 5(2), 197-
209. 
Bishop, S. A., & Neary, J. P. (2018). Assessing prefrontal cortex oxygenation after sport 
concussion with near‐infrared spectroscopy. Clinical physiology and functional imaging, 
38(4), 573-585. 
Cairns, S. P. (2006). Lactic acid and exercise performance. Sports medicine, 36(4), 279-291. 
Canadian Society for Exercise Physiology. (2017). Get active questionnaire.  
Cermak, N. M., Gibala, M. J., & Van Loon, L. J. (2012). Nitrate supplementation’s improvement 
of 10-km time-trial performance in trained cyclists. International Journal of Sport Nutrition 
and Exercise Metabolism, 22(1), 64-71.  
55 
Chance, B., Dait, M. T., Zhang, C., Hamaoka, T., & Hagerman, F. (1992). Recovery from 
exercise-induced desaturation in the quadriceps muscles of elite competitive rowers. 
American Journal of Physiology-Cell Physiology, 262(3), C766-C775. 
Costill, D. L., Dalsky, G. P., & Fink, W. J. (1978). Effects of caffeine ingestion on metabolism 
and exercise performance. Medicine and Science in Sports, 10(3), 155-158.  
Daly, J. W., Jacobson, K. A., & Ukena, D. (1987). Adenosine receptors: Development of 
selective agonists and antagonists. Progress in Clinical and Biological Research, 230, 41-
63.  
Davison, G., Callister, R., Williamson, G., Cooper, K. A., & Gleeson, M. (2012). The effect of 
acute pre-exercise dark chocolate consumption on plasma antioxidant status, oxidative stress 
and immunoendocrine responses to prolonged exercise. European Journal of Nutrition, 
51(1), 69-79.  
Decroix, L., Tonoli, C., Soares, D. D., Tagougui, S., Heyman, E., & Meeusen, R. (2016). Acute 
cocoa flavanol improves cerebral oxygenation without enhancing executive function at rest 
or after exercise. Applied Physiology, Nutrition, and Metabolism, 41(12), 1225-1232.  
Delker, S. L., Xue, F., Li, H., Jamal, J., Silverman, R. B., & Poulos, T. L. (2010). The role of 
zinc in isoform selective inhibitor binding to neuronal nitric oxide synthase. Biochemistry, 
49(51), 10803-10810. doi:10.1021/bi1013479 [doi]  
Ding, E. L., Hutfless, S. M., Ding, X., & Girotra, S. (2006). Chocolate and prevention of 
cardiovascular disease: a systematic review. Nutrition & metabolism, 3(1), 2. 
56 
Di Prampero, P. E., Capelli, C., Pagliaro, P., Antonutto, G., Girardis, M., Zamparo, P., & Soule, 
R. G. (1993). Energetics of best performances in middle-distance running. Journal of 
Applied Physiology (Bethesda, Md.: 1985), 74(5), 2318-2324. 
doi:10.1152/jappl.1993.74.5.2318 [doi]  
Dodd, S. L., Herb, R. A., & Powers, S. K. (1993). Caffeine and exercise performance. Sports 
Medicine, 15(1), 14-23.  
Domínguez, R., Cuenca, E., Maté-Muñoz, J., García-Fernández, P., Serra-Paya, N., Estevan, M., 
... & Garnacho-Castaño, M. (2017). Effects of beetroot juice supplementation on 
cardiorespiratory endurance in athletes. A systematic review. Nutrients, 9(1), 43.  
Drust, B., & Waterhouse, J. (2010). Exercise at altitude. Scottish medical journal, 55(2), 31-34. 
Dulloo, A., Seydoux, J., Girardier, L., Chantre, P., & Vandermander, J. (2000). Green tea and 
thermogenesis: Interactions between catechin-polyphenols, caffeine and sympathetic 
activity. International Journal of Obesity, 24(2), 252.  
Duplain, H., Sartori, C., Lepori, M., Egli, M., Allemann, Y., Nicod, P., & Scherrer, U. (2000). 
Exhaled nitric oxide in high-altitude pulmonary edema: Role in the regulation of pulmonary 
vascular tone and evidence for a role against inflammation. American Journal of 
Respiratory and Critical Care Medicine, 162(1), 221-224.  
Engler, M. B., Engler, M. M., Chen, C. Y., Malloy, M. J., Browne, A., Chiu, E. Y., . . . 
Blumberg, J. (2004). Flavonoid-rich dark chocolate improves endothelial function and 
57 
increases plasma epicatechin concentrations in healthy adults. Journal of the American 
College of Nutrition, 23(3), 197-204.  
Fan, J., O'Donnell, T., Gray, C. L., Croft, K., Noakes, A. K., Koch, H., & Tzeng, Y. (2019). 
Dietary nitrate supplementation enhances cerebrovascular CO2 reactivity in a sex-specific 
manner. Journal of Applied Physiology, 127(3), 760-769. 
Faridi, Z., Njike, V. Y., Dutta, S., Ali, A., & Katz, D. L. (2008). Acute dark chocolate and cocoa 
ingestion and endothelial function: A randomized controlled crossover trial. The American 
Journal of Clinical Nutrition, 88(1), 58-63. doi:88/1/58 [pii]  
Fraga, C. G., Actis-Goretta, L., Ottaviani, J. I., Carrasquedo, F., Lotito, S. B., Lazarus, S., ... & 
Keen, C. L. (2005). Regular consumption of a flavanol-rich chocolate can improve oxidant 
stress in young soccer players. Journal of Immunology Research, 12(1), 11-17. 
Graham, T. E., & Spriet, L. L. (1991). Performance and metabolic responses to a high caffeine 
dose during prolonged exercise. Journal of Applied Physiology (Bethesda, Md.: 1985), 
71(6), 2292-2298. doi:10.1152/jappl.1991.71.6.2292 [doi]  
Graham, T. E. (2001). Caffeine and exercise. Sports Medicine, 31(11), 785-807.  
Harland, B. F. (2000). Caffeine and nutrition. Nutrition, 7(16), 522-526.  
Hill, D. W. (1999). Energy system contributions in middle-distance running events. Journal of 
Sports Sciences, 17(6), 477-483.  
58 
Hill, B. G., Dranka, B. P., Bailey, S. M., Lancaster, J. R., & Darley-Usmar, V. M. (2010). What 
part of NO don't you understand? Some answers to the cardinal questions in nitric oxide 
biology. Journal of Biological Chemistry, 285(26), 19699-19704. 
Huang, S. Y., Alexander, J. K., Grover, R. F., Maher, J. T., McCullough, R. E., McCullough, R. 
G., . . . Reeves, J. T. (1984). Hypocapnia and sustained hypoxia blunt ventilation on arrival 
at high altitude. Journal of Applied Physiology: Respiratory, Environmental and Exercise 
Physiology, 56(3), 602-606. doi:10.1152/jappl.1984.56.3.602 [doi]  
Ide, K., & Secher, N. H. (2000). Cerebral blood flow and metabolism during exercise. Progress 
in neurobiology, 61(4), 397-414. 
JASP Team (2019). JASP (Version 0.10.2)[Computer software]. 
Jeukendrup, A., & Wallis, G. (2005). Measurement of substrate oxidation during exercise by 
means of gas exchange measurements. International Journal of Sports Medicine, 26(S 1), 
S28-S37.  
Jonvik, K. L., Nyakayiru, J., van Loon, L. J., & Verdijk, L. B. (2015). Can elite athletes benefit 
from dietary nitrate supplementation?. Journal of applied physiology, 119(6), 759-761. 
Karim, M., McCormick, K., & Kappagoda, C. T. (2000). Effects of cocoa extracts on 
endothelium-dependent relaxation. The Journal of Nutrition, 130(8), 2105S-2108S.  
Kennedy, M. D., Haykowsky, M. J., Boliek, C. A., Esch, B. T., Scott, J. M., & Warburton, D. E. 
(2006). Regional muscle oxygenation differences in vastus lateralis during different modes 
of incremental exercise. Dynamic Medicine, 5(1), 8. 
59 
Kovacs, E. M., Stegen, J. H., & Brouns, F. (1998). Effect of caffeinated drinks on substrate 
metabolism, caffeine excretion, and performance. Journal of Applied Physiology, 85(2), 
709-715.  
Lansley, K. E., Winyard, P. G., Bailey, S. J., Vanhatalo, A., Wilkerson, D. P., Blackwell, J. R., . . 
. Jones, A. M. (2011). Acute dietary nitrate supplementation improves cycling time trial 
performance. Medicine and Science in Sports and Exercise, 43(6), 1125-1131. 
doi:10.1249/MSS.0b013e31821597b4 [doi]  
Levett, D. Z., Fernandez, B. O., Riley, H. L., Martin, D. S., Mitchell, K., Leckstrom, C. A., . . . 
Montgomery, H. E. (2011). The role of nitrogen oxides in human adaptation to hypoxia. 
Scientific Reports, 1, 109.  
Linnarsson, D., Karlsson, J., Lennart, F., & Benft, S. (1974). Muscle metabolites and oxygen 
deficit with exercise in hypoxia and hyperoxia. Journal of Applied Physiology, 36(4), 399-
402. 
Lucia, A., Joyos, H., & Chicharro, J. L. (2000). Physiological response to professional road 
cycling: climbers vs. time trialists. International journal of sports medicine, 21(07), 505-512. 
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008). The nitrate–nitrite–nitric oxide 
pathway in physiology and therapeutics. Nature Reviews Drug Discovery, 7(2), 156-167. 
doi:10.1038/nrd2466  
60 
MacDonald, M. J., Tarnopolsky, M. A., Green, H. J., & Hughson, R. L. (1999). Comparison of 
femoral blood gases and muscle near-infrared spectroscopy at exercise onset in humans. 
Journal of Applied Physiology, 86(2), 687-693. 
Magalang, U. J., & Grant, B. J. (1995). Determination of gas exchange threshold by 
nonparametric regression. American Journal of Respiratory and Critical Care Medicine, 
151(1), 98-106. doi:10.1164/ajrccm.151.1.7812580 [doi]  
Maki, K. C., Reeves, M. S., Farmer, M., Yasunaga, K., Matsuo, N., Katsuragi, Y., ... & 
Blumberg, J. B. (2008). Green tea catechin consumption enhances exercise-induced 
abdominal fat loss in overweight and obese adults. The Journal of nutrition, 139(2), 264-
270. 
Manach, C., & Donovan, J. L. (2004). Pharmacokinetics and metabolism of dietary flavonoids in 
humans. Free Radical Research, 38(8), 771-786.  
Mancini, D. M., Bolinger, L., Li, H., Kendrick, K., Chance, B., & Wilson, J. R. (1994). 
Validation of near-infrared spectroscopy in humans. Journal of Applied Physiology, 77(6), 
2740-2747.  
Masschelein, E., Van Thienen, R., Wang, X., Van Schepdael, A., Thomis, M., & Hespel, P. 
(2012). Dietary nitrate improves muscle but not cerebral oxygenation status during exercise 
in hypoxia. Journal of Applied Physiology (Bethesda, Md.: 1985), 113(5), 736-745. 
doi:10.1152/japplphysiol.01253.2011 [doi]  
61 
Maughan, R. J., Depiesse, F., & Geyer, H. (2007). The use of dietary supplements by athletes. 
Journal of Sports Sciences, 25(S1), S103-S113.  
McArdle, W.D., Katch, F.I., and Katch, V.L. (2015). Exercise Physiology: Energy, 
Nutrition & Human Performance. 8th Edition. Lippincott Williams & Wilkins: New York, 
NY 
McCall, A., Millington, W., & Wurtman, R. (1982). Blood-brain barrier transport of caffeine: 
Dose-related restriction of adenine transport. Life Sciences, 31(24), 2709-2715.  
McClelland, G. B., Hochachka, P. W., & Weber, J. M. (1998). Carbohydrate utilization during 
exercise after high-altitude acclimation: A new perspective. Proceedings of the National 
Academy of Sciences of the United States of America, 95(17), 10288-10293. 
doi:10.1073/pnas.95.17.10288 [doi]  
McKenna, M. J., Heigenhauser, G. J., McKelvie, R. S., MacDougall, J. D., & Jones, N. L. 
(1997). Sprint training enhances ionic regulation during intense exercise in men. The 
Journal of Physiology, 501(3), 687-702.  
Meng, C. C., Jalil, A. M. M., & Ismail, A. (2009). Phenolic and theobromine contents of 
commercial dark, milk and white chocolates on the malaysian market. Molecules, 14(1), 
200-209.  
Miller, K. B., Hurst, W. J., Payne, M. J., Stuart, D. A., Apgar, J., Sweigart, D. S., & Ou, B. 
(2008). Impact of alkalization on the antioxidant and flavanol content of commercial cocoa 
powders. Journal of agricultural and food chemistry, 56(18), 8527-8533. 
62 
Mitchell, E., Slettenaar, M., Vd Meer, N., Transler, C., Jans, L., Quadt, F., & Berry, M. (2011). 
Differential contributions of theobromine and caffeine on mood, psychomotor performance 
and blood pressure. Physiology & Behavior, 104(5), 816-822.  
Muggeridge, D. J., Howe, C., Spendiff, O., Pedlar, C., James, P. E., & Easton, C. (2014). A 
single dose of beetroot juice enhances cycling performance in simulated altitude. 
Med.Sci.Sports Exerc, 46(1), 143-150.  
Mughal, A., Sun, C., & O’Rourke, S. T. (2018). Activation of large conductance, calcium-
activated potassium channels by nitric oxide mediates apelin-induced relaxation of isolated 
rat coronary arteries. Journal of Pharmacology and Experimental Therapeutics, 366(2), 265-
273. 
Nehlig, A., & Debry, G. (1994). Caffeine and sports activity: A review. International Journal of 
Sports Medicine, 15(05), 215-223.  
Neufingerl, N., Zebregs, Y. E., Schuring, E. A., & Trautwein, E. A. (2013). Effect of cocoa and 
theobromine consumption on serum HDL-cholesterol concentrations: A randomized 
controlled trial. The American Journal of Clinical Nutrition, 97(6), 1201-1209.  
Nogueira, L., Ramirez‐Sanchez, I., Perkins, G. A., Murphy, A., Taub, P. R., Ceballos, G., . . . 
Malek, M. H. (2011). (–)‐Epicatechin enhances fatigue resistance and oxidative capacity in 
mouse muscle. The Journal of Physiology, 589(18), 4615-4631.  
Nybo, L., & Rasmussen, P. (2007). Inadequate cerebral oxygen delivery and central fatigue 
during strenuous exercise. Exercise and sport sciences reviews, 35(3), 110-118. 
63 
Ørtenblad, N., Westerblad, H., & Nielsen, J. (2013). Muscle glycogen stores and fatigue. The 
Journal of Physiology, 591(18), 4405-4413.  
Pappano, A. J., & Wier, W. G. (2012). Cardiovascular Physiology E-Book: Mosby Physiology 
Monograph Series. Elsevier Health Sciences. 
Patel, R. K., Brouner, J., & Spendiff, O. (2015). Dark chocolate supplementation reduces the 
oxygen cost of moderate intensity cycling. Journal of the International Society of Sports 
Nutrition, 12, 10.1186/s12970-015-0106-7. doi:106 [pii]  
Péronnet, F., & Aguilaniu, B. (2006). Lactic acid buffering, nonmetabolic CO2 and exercise 
hyperventilation: a critical reappraisal. Respiratory physiology & neurobiology, 150(1), 4-
18. 
Peronnet, F., & Thibault, G. (1989). Mathematical analysis of running performance and world 
running records. Journal of Applied Physiology (Bethesda, Md.: 1985), 67(1), 453-465. 
doi:10.1152/jappl.1989.67.1.453 [doi]  
Peschek, K., Pritchett, R., Bergman, E., & Pritchett, K. (2014). The effects of acute post exercise 
consumption of two cocoa-based beverages with varying flavanol content on indices of 
muscle recovery following downhill treadmill running. Nutrients, 6(1), 50-62.  
Powers, S. K., & Dodd, S. (1985). Caffeine and endurance performance. Sports Medicine, 2(3), 
165-174.  
64 
Quinlan, P., Lane, J., & Aspinall, L. (1997). Effects of hot tea, coffee and water ingestion on 
physiological responses and mood: The role of caffeine, water and beverage type. 
Psychopharmacology, 134(2), 164-173.  
Sanguigni, V., Manco, M., Sorge, R., Gnessi, L., & Francomano, D. (2017). Natural antioxidant 
ice cream acutely reduces oxidative stress and improves vascular function and physical 
performance in healthy individuals. Nutrition, 33, 225-233.  
Saris, W., van Erp-Baart, M., Brouns, F., Westerterp, K., & Ten Hoor, F. (1989). Study on food 
intake and energy expenditure during extreme sustained exercise: The tour de france. 
International Journal of Sports Medicine, 10(S 1), S26-S31.  
Schewe, T., Steffen, Y., & Sies, H. (2008). How do dietary flavanols improve vascular function? 
A position paper. Archives of Biochemistry and Biophysics, 476(2), 102-106.  
Secher, N. H., Seifert, T., & Van Lieshout, J. J. (2008). Cerebral blood flow and metabolism 
during exercise: Implications for fatigue. Journal of Applied Physiology, 104(1), 306-314.  
Siebenmann, C., Sørensen, H., Jacobs, R. A., Haider, T., Rasmussen, P., & Lundby, C. (2013). 
Hypocapnia during hypoxic exercise and its impact on cerebral oxygenation, ventilation and 
maximal whole body O2 uptake. Respiratory physiology & neurobiology, 185(2), 461-467. 
Simonson, S. G., & Piantadosi, C. A. (1996). Near-infrared spectroscopy: clinical applications. 
Critical care clinics, 12(4), 1019-1029. 
Snyder, A. C. (1998). Overtraining and glycogen depletion hypothesis. Medicine and Science in 
Sports and Exercise, 30(7), 1146-1150.  
65 
Sokmen, B., Armstrong, L. E., Kraemer, W. J., Casa, D. J., Dias, J. C., Judelson, D. A., & 
Maresh, C. M. (2008). Caffeine use in sports: Considerations for the athlete. Journal of 
Strength and Conditioning Research, 22(3), 978-986. doi:10.1519/JSC.0b013e3181660cec 
[doi]  
Somerville, V., Bringans, C., & Braakhuis, A. (2017). Polyphenols and performance: A 
systematic review and meta-analysis. Sports Medicine, 47(8), 1589-1599.  
Spencer, M. R., & Gastin, P. B. (2001). Energy system contribution during 200-to 1500-m 
running in highly trained athletes. Medicine & Science in Sports & Exercise, 33(1), 157-
162.  
Stellingwerff, T., Godin, J., Chou, C. J., Grathwohl, D., Ross, A. B., Cooper, K. A., . . . Actis-
Goretta, L. (2013). The effect of acute dark chocolate consumption on carbohydrate 
metabolism and performance during rest and exercise. Applied Physiology, Nutrition, and 
Metabolism, 39(2), 173-182.  
Stenberg, J., Ekblom, B., & Messin, R. (1966). Hemodynamic response to work at simulated 
altitude, 4,000 m. Journal of Applied Physiology, 21(5), 1589-1594. 
doi:10.1152/jappl.1966.21.5.1589 [doi]  
Strobel, P., Allard, C., Perez-Acle, T., Calderon, R., Aldunate, R., & Leighton, F. (2005). 
Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. 
The Biochemical Journal, 386(Pt 3), 471-478. doi:BJ20040703 [pii]  
66 
Subudhi, A. W., Dimmen, A. C., & Roach, R. C. (2007). Effects of acute hypoxia on cerebral 
and muscle oxygenation during incremental exercise. Journal of Applied Physiology, 
103(1), 177-183.  
Sudarma, V., Sukmaniah, S., & Siregar, P. (2011). Effect of dark chocolate on nitric oxide serum 
levels and blood pressure in prehypertension subjects. Acta Med Indones, 43(4), 224-228.  
Tarnopolsky, M. A. (1994). Caffeine and endurance performance. Sports Medicine, 18(2), 109-
125.  
Taub, P. R., Ramirez-Sanchez, I., Patel, M., Higginbotham, E., Moreno-Ulloa, A., Román-
Pintos, L. M., . . . Villarreal, F. (2016). Beneficial effects of dark chocolate on exercise 
capacity in sedentary subjects: Underlying mechanisms. A double blind, randomized, 
placebo controlled trial. Food & Function, 7(9), 3686-3693.  
Vanhatalo, A., Fulford, J., Bailey, S. J., Blackwell, J. R., Winyard, P. G., & Jones, A. M. (2011). 
Dietary nitrate reduces muscle metabolic perturbation and improves exercise tolerance in 
hypoxia. The Journal of Physiology, 589(22), 5517-5528.  
Vogt, S., Heinrich, L., Schumacher, Y. O., Blum, A., Roecker, K., Dickhuth, H. H., & Schmid, 
A. (2006). Power output during stage racing in professional road cycling. Medicine and 
science in sports and exercise, 38(1), 147. 
Ward-Smith, A. (1985). A mathematical theory of running, based on the first law of 
thermodynamics, and its application to the performance of world-class athletes. Journal of 
Biomechanics, 18(5), 337-349.  
67 
Westerblad, H., & Allen, D. G. (1991). Changes of myoplasmic calcium concentration during 
fatigue in single mouse muscle fibers. The Journal of General Physiology, 98(3), 615-635. 
doi:10.1085/jgp.98.3.615 [doi]  
Woo, J. S., Derleth, C., Stratton, J. R., & Levy, W. C. (2006). The influence of age, gender, and 

































































Appendix B- Consent Form 
 
  
Participant Information and Consent Form 
Title:  The effect of dark chocolate on metabolism and performance in trained cyclists at simulated altitude 
Principal Investigator: Philip D. Chilibeck, Ph.D., Professor, College of Kinesiology, University of 
Saskatchewan, phone: 306-966-1072 
Co-Investigator: Patrick Neary, Ph.D. Professor, Faculty of Kinesiology and Health Studies, University of 
Regina,  phone: 306-585-4844:  
Student Researchers: Keely Shaw, B.Sc.  (graduate student supervised by Philip Chilibeck), College of 
Kinesiology, University of Saskatchewan, phone: 306-966-1082  
Emergency Telephone Number (Philip Chilibeck): 306-230-3849 
Introduction 
You are invited to take part in this research study because you are an experienced cyclist and we want to 
determine the effects of a dark chocolate compared to a dark chocolate flavored placebo (i.e. an artificial 
chocolate that simulates dark chocolate, but lacks cocoa liquor) on your cycling performance at a simulated 
altitude of 2500m and recovery from exercise. 
Your participation is voluntary. It is up to you to decide whether or not you wish to take part. If you decide to 
participate, you are still free to withdraw at any time and without giving any reasons for your decision. If you 
do not wish to participate, you will not affect your relationship with the researchers or the university. 
Please take time to read the following information carefully. You can ask the study staff to explain any 
information that you do not clearly understand. You may ask as many questions as you need. Please feel free to 
discuss this with your family, friends or family physician before you decide. 
Who is conducting the study? 
Dr. Chilibeck of the College of Kinesiology at the University of Saskatchewan and Patrick Neary of the 
Faculty of Kinesiology and Health Studies at the University of Regina are conducting this study. 
Why is this study being done? 
This study is being done because the research team wants to determine the effectiveness of dark chocolate for 
improving performance during exercise at simulated altitude and for improving recovery from exercise. This 
will inform coaches and athletes if dark chocolate is an effective nutritional supplement for endurance 
performance at altitude. 
Who can participate in this study? 
You are eligible to participate in this study if you are male or female 18 years of age or older and are an 
experienced cyclist (i.e. bicycle exercise at a vigorous intensity on a regular basis and have above average 
aerobic fitness. A “vigorous intensity” means that you bicycle at an intensity that elicits heavy breathing. 
“Regular” is defined as at least three times per week for 60 minutes). The researchers will determine whether 
exercise testing is safe for you by having you fill out a brief questionnaire (the Get Active Questionnaire) after 
you have signed this consent form but before you do any exercise testing. If there is doubt about the safety of 
exercise participation for you based on this questionnaire, the researchers will require that you get clearance 
from a health care professional before you participate. You should not participate if you have any allergies to 
chocolate.  
What does the study involve? 
There will be 7 study visits to our lab. About half of the testing (study visits) will be done to evaluate one of 
the treatments (dark chocolate or the dark chocolate flavoured placebo). A month later, the other visits will be 
done to evaluate the opposite treatment. 
Visit #1 will consist of an aerobic capacity test on a cycle ergometer (i.e. a stationary bike) to determine fitness 
level and eligibility for the study. This involves cycling at a progressively increasing workload until volitional 
fatigue. During the test, we will measure respiratory gases by having you breathe into a mouthpiece. The test 
will last approximately 10-15 minutes, depending on your fitness level. 
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Visit #2 will consist of assessing the reactivity of your blood vessels, testing for maximal knee extension 
strength, determination of fatigue of the knee extensors through repeated contractions, a second aerobic 
capacity test at a simulated altitude of 2500m, and a 10km time trial at simulated altitude. The assessment of 
your blood vessels includes reducing the blood flow in your arm for 5 minutes by inflating a blood pressure 
cuff, releasing it, and assessing the reaction of the blood vessels using ultrasound. The knee extension strength 
test will require that you exert as much force as possible on a machine with the front of your leg while in a 
seated position (i.e. knee extension). You will be asked to exert force for 5 seconds. You will take a 1-minute 
rest and then we will test the rate at which your quadriceps fatigue through 10 repeated maximal contractions.  
EMG stickers will be applied to your thigh in order to assess the electrical activity of your muscle.. The 
purpose of this test is to evaluate the amount of muscle fatigue you have from previous exercise. You will then 
do an aerobic cycling test at simulated altitude. The aerobic capacity test involves pedaling on a stationary bike 
with resistance increasing every minute until volitional fatigue insde a chamber that has reduced oxygen 
content (to simulate conditions at about 2,500 m altitude). The test takes about 10-15 minutes, depending on 
your fitness level. During the test, oxygen consumption is measured through a mouthpiece and the level of 
oxygen consumption is used as a measure of aerobic fitness. Visit #2 will also include a practice of a 10km 
time trial on a stationary bike, which will be the performance indicator in the chocolate testing. During the 10 
km time trial, you will cover 10 km as fast as possible on a stationary bike, again inside the chamber with 
reduced oxygen content to simulate altitude. You will be able to see how much distance you have covered, but 
you will not know how much time has elapsed. This entire lab visit will last about 2 hours. 
Visit #3 will consist of a familiarization trial using the cycling test used in the study. You will be asked to 
cycle for 90 minutes at a simulated altitude of 2500m on a stationary bike at an intensity corresponding to 60% 
of the maximal oxygen uptake reached during the aerobic capacity test done at simulated altitude (visit #2) 
followed by a 10km time trial, where you will cycle as fast as possible until you cover the equivalent of 10 km. 
You will be able to see the distance covered on the bike display, but you will not be able to see the speed you 
are cycling at. The familiarization trial is necessary to reduce the amount of variability across subsequent 
testing sessions (i.e. the subsequent testing sessions which compare dark chocolate to the control placebo 
chocolate). This lab visit will take about 105 minutes. 
After visit #3, before you leave the lab after performing the exercises, you will be randomized (i.e. assigned by 
chance by a computer) to receive either dark chocolate or a dark chocolate flavoured placebo (i.e. a substance 
that looks and tastes like dark chocolate, but which contains none of the active ingredients found in dark 
chocolate). You will not know which chocolate you are receiving. The chocolate will be supplied to you in 
individual portions for each serving. This will be consumed twice a day (60g per per dose at breakfast and 
before going to bed) for 14 days. Two days before visit #4 (i.e. on the 13th and 14th day of the chocolate 
supplementation) we want you to try to minimize the amount of fruits, vegetables, tea, coffee, alcohol, 
chocolate, cereals, whole meal bread, and grains you consume because these foods contain some of the same 
beneficial ingredients as the dark chocolate. You will be given a food diary to record all foods and drinks you 
consume for these two days. These diaries will be photocopied and given back for the testing of the opposite 
condition (i.e. dark chocolate or chocolate flavoured placebo) in the next phase. 
Visit #4 will occur on the 15th day of chocolate supplementation.  
• You will come into the lab after a 10 hour fast.  
• You will have your blood tested for lactate and glucose by finger prick sample 
• You will be tested again for reactivity of your blood vessels 
• You will be tested again for maximal isometric voluntary contraction and fatigue through repeated 
contractions 
• You will then be given 60 grams of either dark chocolate or the dark chocolate flavored placebo 60 
minutes before exercise testing. Neither you nor the researcher will know which chocolate you are 
receiving. The chocolate will be prepared by a different research assistant who is not involved with 
administering the exercise test.  
• The exercise testing will involve 90 minutes of cycling at a simulated altitude of 2500m at 60% of the 
workload reached on the aerobic capacity test in visit #2, followed by a 10 km time trial where you 
will cover 10 km as fast as you can. 
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•  After the time trial, you will engage in a 10 minute cool down followed by another test of maximal 
voluntary contraction and fatigue through repeated contractions 
• The total amount of time for this study visit will be about 3 hours. 
• Visit #5 to the lab will occur the next morning, again in a fasted state (at least 10 hours fasted). You 
will be given 60g of dark chocolate or dark chocolate flavored placebo to consume. Thirty minutes 
after consumption the chocolate, maximal voluntary contraction, and fatigue through repeated 
contractions will be determined. 
Visits #6 and 7 will occur a month later after 14 days of dark chocolate or dark chocolate flavoured placebo 
supplementation (i.e. the opposite condition to what you received prior to visit #3). All testing will be identical 
to tests in visits #4 and 5  
There will be a total of 12 participants in the study. 
The total time for study visits is about 12 hours. 
What are the benefits of participating in this study? 
You will receive an assessment of your aerobic fitness. You will receive this after completion of visit 1. The 
results of the study will help athletes and coaches decide whether dark chocolate is beneficial for sport 
performance and recovery. These benefits are not guaranteed. 
What are alternatives to the study? 
You do not have to participate in this study to receive these benefits. You can receive an assessment of your 
aerobic fitness through appointments with a personal trainer through the Faculty  of Kinesiology and Health 
Studies. 
What are the possible risks and discomforts? 
The exercise testing may cause some discomfort and there is a small risk of injury. Trained personnel will 
administer all testing to minimize the risks.  
There may be risk of feeling faint or nauseous when exercising in a fasted state. 
There may be risk of feeling faint or nauseous when exposed to simulated altitude. 
What happens if I decide to withdraw? 
Your participation in this research is voluntary. You may withdraw from this study at any time. You do not 
have to provide a reason. Your relationships with the researchers or the university will not be affected.  
If you choose to enter the study and then decide to withdraw at a later time, all data collected about you during 
your enrolment will be retained for analysis.  
What happens if something goes wrong? 
If an adverse event related to the study occurs, trained staff will be available throughout the conduct of the 
study who can respond immediately.  Necessary medical treatment will be made available at no additional cost 
to you. As soon as possible, notify the research team. By signing this document, you do not waive any of your 
legal rights. 
What happens after completion of the study? 
The researchers will inform you of the overall study results, as well as your individual results, after they have 
analyzed all data (approximately April 2019) by sending you an email. You will receive results of your test of 
maximal aerobic capacity the same day of the test.  
What will the study cost me? 
You will not be charged for the chocolate or any research-related procedures. 
Will my Study Data be Kept Confidential? 
In Saskatchewan, the Health Information Protection Act (HIPA) defines how the privacy of your personal 
health information must be maintained so that your privacy will be respected. The study data will be stored 
securely (in a locked cabinet contained within a locked office under the supervision of the PI) by the study 
team for a minimum of 5 years after the final results are published.  Research records identifying you may be 
inspected by the University of Saskatchewan Biomedical Research Ethics Board for quality assurance and 
monitoring purposes. 
It is the intention of the research team to publish results of this research in scientific journals and to present the 
findings at related conferences and workshops, but your identity will not be disclosed. 
Who do I contact if I have questions about the study? 
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If you have any questions or desire further information about this study before or during participation, 
you can contact Philip Chilibeck at 306-966-1072 or phil.chilibeck@usask.ca 
If you have any concerns about your rights as a research participant and/or your experiences while 
participating in this study, contact the Chair of the University of Saskatchewan Research Ethics Board, at 306-
966-2975 (out of town calls 1-888-966-2975). The Research Ethics Board is a group of individuals (scientists, 
physicians, ethicists, lawyers and members of the community) that provide an independent review of human 
research studies. This study has been reviewed and approved on ethical grounds by the University of 
Saskatchewan Research Ethics Board.  
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CONSENT TO PARTICIPATE 
 
o I have read the information in this consent form. 
o I understand the purpose and procedures and the possible risks and benefits of the study.  
o I have been informed of the alternatives to the study.  
o I was given sufficient time to think about it. 
o I had the opportunity to ask questions and have received satisfactory answers. 
o I am free to withdraw from this study at any time for any reason and the decision to stop taking part 
will not affect my future relationships at the university. 
o I agree to follow the principal investigator's instructions and will tell the principal investigator at once 
if I feel I have had any unexpected or unusual symptoms. 
o I have been informed there is no guarantee that this study will provide any benefits to me.  
o I understand that by signing this document I do not waive any of my legal rights. 
o I will be given a signed and dated copy of this consent form. 
 
 
Printed name of participant:     ______________________                  
Signature  _______________________      Date___________________________  
Printed name of person obtaining consent: _____________________       
Signature  _________________________ Date___ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
